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SUMMARY
Cutaneous m alignant melanoma is the third most common variety of 
skin cancer. Basal cell carcinoma and squamous cell carcinoma take first 
and second places respectively. Like the other two types of tum our, 
m alignant melanoma occurs more commonly in sunny areas and the 
highest incidence rates are reported in countries near the equator. Basal 
and squam ous carcinomas show a clear-cut relationship with chronic sun 
exposure occurring mainly in older age groups and on habitually exposed 
sites. M alignant m elanomas, however, present in individuals w ith  a 
mean age of only 48 years and may occur in both exposed and unexposed 
sites.
From the patient's point of view the most im portant difference betw een 
m alignant melanoma and the other two skin cancers is their potential for 
m etastatic spread. M alignant melanomas may spread to local lym ph 
nodes and also to other body sites especially the lungs, liver and bones. 
A lthough prim ary melanoma and some local nodes are accessible to 
surgery, once internal nodes and organs are involved further surgery is 
usually impossible. Melanomas occurring in these latter sites are also 
com paratively  resistan t to rad io therapy  and curren tly  availab le  
chem otherapy. In contrast, the behaviour of basal and squam ous 
carcinomas is usually less aggressive. Squamous carcinomas tend  to 
spread relatively slowly to local lymph nodes and systemic involvem ent 
is rare. Basal cell carcinomas spread locally causing tissue destruction but 
rarely m etastasize. Thus m alignant m elanom a is relatively unique 
am ong skin m alignancies in being associated w ith  a considerable 
mortality rate.
IX
Recently considerable attention has been draw n to malignant melanoma 
by the marked changes being observed in its incidence rate. In the last 
decade doubling of incidence has been noted w ithin Scandinavia and 
parts of America. The incidence in Scotland, a country of low melanoma 
incidence, has almost doubled since 1979. The change is felt to be due to 
increased sun exposure in recent years. The greater exposure could reflect 
alterations in environmental factors such as thinning of the protective 
ozone layer of the atmosphere with increased transmission of ultra violet 
light to earth or could be due to altered, behaviour patterns w ith more 
participation in outdoor sports and leisure activities.
In the absence of a correctable aetiological factor for melanoma and its 
rising rate there is presently no possibility of m ounting a prim ary 
m elanoma preventative campaign. The m ost appropriate endeavour 
w ould be to encourage its earlier diagnosis. It is recognized that 
m elanom as w ith high thickness m easurem ents are m ore likely to 
metastasize and thus contribute to m ortality rates than ones w ith low 
"thin" m easurem ents. If one assum es that "thin" m elanom as are 
diagnosed earlier than thick ones, the encouragement of earlier diagnoses 
and treatment of melanoma should improve its overall prognosis.
Public education on melanoma diagnosis has been underw ay for some 
twenty years in Queensland, Australia, the centre w ith the highest w orld­
wide incidence. The running of this educational venture has coincided 
w ith a rise in the proportion of th in  lesions being seen and an 
im provem ent in overall m elanom a prognosis. The situa tion  in 
Australia contrasted m arkedly w ith that in Scotland w here a high 
proportion of melanomas were thick and the overall prognosis was poor. 
Closer study of the West of Scotland patients (about half of the total for
X
Scotland) revealed that the vast majority of patients had delayed in 
seeking advice about their melanomas due to lack of knowledge on the 
subject.
This observation confirmed a view that public education on melanoma 
w ould be useful in Scotland and led to the running of the Glasgow 
M elanoma Campaign in 1985. This involved production and design of 
educational materials on the subject and dissem ination of inform ation 
using all available types of media. This public education venture was 
preceded, at the request of local general practitioners, by an active 
professional update programme for those involved in prim ary care.
The unique aspect of the Glasgow Campaign was the great effort made to 
evaluate the effects of education. This was done by careful monitoring of 
referral patterns of pigmented lesions, numbers and types of melanomas 
and num bers of pigmented lesions submitted for histological evaluation. 
These figures thus reflected the workload resulting from the campaign as 
well as its effect on melanoma rates. All this data was collected for the 
campaign year itself and for a full year before and after it.
The education campaign resulted in considerable publicity. There was a 
m arked rise in the num bers of patients referred to hospital w ith  
pigm ented lesions and a much smaller rise in the num bers of excised 
pigm ented lesions. The most gratifying result was the m arked increase 
in the proportion of melanom a patients presenting w ith thin, good 
prognosis lesions during  the cam paign. The m ajority of patients 
attending dermatology clinics during the campaign year had heard of the 
work, usually by television publicity.
XI
The Glasgow venture formed a model for a 7 centre melanoma education 
campaign run  by the Cancer Research Cam paign in 1987. The early 
results of m elanom a education have been encouraging and further 
thought may be given to repeating this type of exercise in the future.
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CHAPTER ONE
INTRODUCTION
1.1 General Comments
C utaneous m alignant m elanom a (MM) is the th ird  m ost com m on 
variety of skin cancer after basal cell carcinoma (BCC) and squamous cell 
carcinoma (SCC). There are many similarities between BCCs and SCCs in 
term s of the type of individual affected, the most commonly involved 
site(s) and the geographical variations in their incidences. Both BCC and 
SCC occur most frequently but not exclusively in people and parts of the 
body w ith above average chronic sun exposure.(1) In Britain, they most 
frequently present on the face, dorsum  of hands and neck of those aged 
more than 60 years who have had predom inantly outdoor occupations. 
A recent Australian study has shown that individuals whose skin has 
poor natural sun tolerance ie the fair skinned and blue eyed tend to 
have a higher incidence of both tumours than dark-skinned and brow n­
eyed people.(2) W orld-wide the incidence of all three types of these 
tum ours is highest at the equator and the rate is inversely proportional to 
latitude.(3)
The m ost frequent presentation of BCC is as a non-healing usually 
asymptomatic nodule which has been present for months or even years 
on the face. These nodules m ay show superficial ulceration and can 
contain variable amounts of pigment. Less commonly BCCs may be of the 
superficial variety presenting as hyperkeratotic, reddish patches often on
the trunk. A variety of possible aetiological factors other than chronic 
ultraviolet light exposure have been linked to the occurrence of BCC. 
These include prior treatment of the involved skin with radiotherapy (4), 
chronic venous stasis (4) and occupational, industrial or m edicinal 
exposure to arsenic (5)
SCCs are also usually asymptomatic but tend to have a more aggressive, 
rapidly growing history. They occur much less frequently than BCC but 
share several aetiological associations. These include ultraviolet light 
exposure (6), occupational radiation (6), arsenic exposure (7) and previous 
scarring. (8) There are recognisable pre-invasive (in-situ) forms of SCC 
like Bowen's disease and actinic keratoses. W ork from A ustralia has 
suggested that only a small proportion of actinic keratoses progress to 
invasive squamous cancer. (9) In this study 1040 patients with at least one 
actinic keratosis were followed up. More than a th ird  of patien ts 
experienced remission of at least one lesion. The authors concluded that 
it w as probable that less than 1% of actinic keratoses progressed to 
squam ous cancers.
Both BCC and SCC are curable by simple surgery if diagnosed early 
although more complex techniques like grafting may be necessary for 
larger, m ore long-standing lesions. In patients in whom  surgery is 
considered to be inappropriate, radiotherapy may be a useful alternative 
for either type of tumour. It is rare for BCCs to metastasise and local 
invasion  w ith  subsequent tissue dam age is the m ost frequently  
encountered serious consequence. Only in the rare cases w here this 
causes damage to vital structures do BCCs result in death. In contrast, 
squam ous cancers do metastasise, most often to the regional lym ph
nodes. The frequency of métastasés in association with SCCs varies from 
0-50% depending on the series quoted. In a series reported by Katz of 
mainly ultra-violet exposure related SCCs a metastatic rate of 2.6% was 
observed. (10) This rate is much lower than that seen in series of SCCs 
arising for reasons other than ultra violet exposure eg those related to 
scars or to prior irradiation. (11) Both BCCs and SCCs have m orbidity 
rates according to their site, size and extent of treatment required.
Cutaneous malignant melanoma (MM) differs in m any ways from the 
other two types of skin cancer. It can occur, albeit very rarely, in 
childhood (12) and incidence tends to increase w ith increasing age. 
W orld-wide the average age at presentation is much younger than for 
BCC or SCC. One overview of the subject quotes a mean age of only 48 
worldwide (13) while the mean age of a group of Scottish patients was 54. 
(18) Although more frequent in sunny countries MM incidence does not 
show  the same clear-cut relationship to latitude.(v.i.). It can occur 
anywhere on the body including areas like the perineum  which have no 
direct sun exposure. There are, however, favoured sites w here MM 
occurs most frequently, namely the lower leg in women and the trunk in 
m en.
From the patient's point of view, the most im portant difference between 
MM and the other two types of skin cancer is that MM not infrequently 
metastasises. This process can involve not only the regional lym ph nodes 
bu t also major organs like the liver, lungs and brain. Once this has 
occurred MM is largely resistant to currently  available trea tm en t 
m odalities like radiotherapy and chem otherapy. Thus MM carries a 
significant mortality as well as morbidity rate.
1.2 Epidemiology
Today the area w ith  the highest W orld-w ide MM incidence is 
Queensland, Australia (13) with a rate of 35 per 100,000 population per 
annum . A m arked variation in MM m ortality w ith latitude has been 
reported w ithin Australia itself.(14) Queensland (latitude 11-29 S) had 
the highest rate. New South Wales (latitude 28-37 S) an intermediate rate 
and Victoria (latitude 34-39 S) a low rate. These variations in mortality 
rates presum ably reflect a latitude related incidence variation. H igh 
incidence rates have also been reported from parts of the USA notably 
from Arizona (15), New Mexico (17) and Hawaii. (16) Scotland and 
indeed Britain as a whole has a low incidence currently 7.1% for men and 
10.4% for wom en per 100,000 population  per year. ((18), Scottish 
Melanoma Group data) However, comparison of incidence data from 
reported series can be difficult for two m ain reasons. Firstly, in some 
series in-situ as well as true invasive MMs are included while other 
centres, such as Scotland, only register invasive lesions. As the 
histological distinction between dysplastic naevus and in-situ MM can be 
difficult, variations in reporting habits may result in apparently greater 
num bers of in-situ MMs in some laboratories. If these lesions are then 
registered as MMs an artificially high incidence rate may be reported.
Secondly, there may be considerable variation in the sizes and types of the 
population bases on which MM incidence rates are calculated. The 
Scottish Melanoma Group (SMG) data is almost unique in being based on 
the whole population of Scotland. Registrations are received from all 
private and National Health Hospitals in the country. Due to the present 
health  care system this means that virtually  all Scottish MMs are
registered whereas in countries like the USA a significant proportion of 
lesions are removed by private practitioners outside the hospital setting. 
In the latter case there may thus be under- registration. Some published 
incidence rates may be calculated on selected populations e.g. those 
a ttend ing  specific hospitals or specific derm atologists w ith in  an 
Am erican state. (15) The most useful data is that from unselected 
populations.
Variations in incidence related to latitude have been sought in areas of 
both high and low incidence. An inverse relationship between latitude 
and incidence has been demonstrated within England and Wales (19) and 
w ithin Norway. (20) These patterns seem to be best observed w ithin 
sim ilar types of population i.e. within one country. The latitude effect 
may be much less clear across more diverse populations e.g. although 
Scandinavia and England are at the same latitude the former previously 
reported a much higher MM incidence. (21)
There is a marked racial variation in MM incidence. It is a rare tum our 
in Negro races and uncommon in M editerranean and Oriental peoples. 
(1) Data from the south east USA showed that only 3% of melanomas 
occurred in black patients while 26% of the local population were black. 
(22) Likewise in a survey of melanomas in the USA, 98% of patients were 
white, 1% black and 1% "other" eg Hispanic or oriental. (23) Interestingly 
this study  also noted that the melanomas seen in the black patients 
tended to favour the less pigmented sites. A total of 49% of melanomas in 
black individuals were located on the sole an unusual site for white 
patients w ith melanomas. A country's overall MM risk is thus partly 
related to the skin pigmentation of its indigenous population.
An apparently MM- susceptible phenotype has been distinguished in 
various studies of MM patients. The Western Canada Melanoma Study 
involved interviewing 665 melanoma patients and control individuals 
matched for age, sex and province of residence. The final evaluation was 
based on 595 case-control pairs. During the interview note was made of 
hair and eye colour, freckling tendency and sun-sensitivity in both adult 
and childhood years. Skin types were defined in terms of tanning ability 
and liability to burning. (24) The study found that individuals w ith 
blonde hair, light skin colour and blue eyes had relative MM risks of 9.7, 
3.4,and 1.6 respectively compared with those w ith dark hair, dark skin 
and brown eyes. Likewise people whose skin tended to bum  rather than 
tan in the sun had a risk of 2.3 compared to those who tanned and didn't 
burn. In a similar type of case-control study, Beral noted that light hair 
colour was the strongest risk factor followed by light skin colour. (25)
It is recognised that MM may be familial in that 10% of cases have MM 
occurring in a first degree relative. (26) In some families this increased 
risk was noted to be associated w ith the presence of large, clinically 
atypical naevi, a combination initially term ed the B-K mole syndrom e 
after the two original families described. (27) A second group described 
this association and coined the term  familial atypical m ultiple mole 
melanoma (FAMM) syndrome.(28) The most recently suggested term, is 
the familial dysplastic naevus syndrom e (DNS). Further observations 
found that the combination of atypical naevi and MM may also occur 
sporadically i.e. in the absence of a family history of melanoma. A 
tendency to the same pattern of atypical naevi has also been observed 
w ithin families with no history of MM. (29)
Since it was first described DNS has been a subject of controversy. The 
initially described clinical features of these naevi were that they were 
larger than  o rd inary  acquired moles, irregu lar in outline  and  
pigm entation, occurred in unusual sites like the scalp and breast and 
were present in very large numbers. (29) Early work by Kelly and Sagebiel 
also suggested that this clinical appearance correlated w ith  atypical 
histological features. (30) These workers looked at 165 naevi excised from 
ind iv iduals who had  previously had histologically atypical naevi 
removed. The lesions were classified on pathological grounds as showing 
mild, m oderate or severe dysplasia. They found that in 75% of cases in 
w hom  atypia had been suspected on clinical grounds histological 
confirmation of dysplasia was obtained. Enlarged clinical photographs of 
the naevi were then reviewed and the features which correlated best w ith 
histological dysplasia were noted. These were an ill-defined border, 
irregular pigmentation, diameter > 0.5cm, erythema and accentuated skin 
m arkings. They concluded that "clinical exam ination constitutes a 
p ractical and sufficiently reliable m ethod for the assessm ent of 
m elanocytic naevi in patients w ith  dysplastic naevus syndrom e". 
However, more recent work has shown that histological atypia m ay be 
observed in clinically banal naevi while clinically abnormal naevi may be 
histologically benign. (31)
It has also been found that some people have small num bers of clinically 
atypical naevi. Crutcher and Sagebiel perform ed skin examinations on 
881 patients in California excluding individuals w ith personal or family 
histories of melanoma or those who had been referred w ith a specific 
pigm ented lesion. They noted clinically and histologically confirm ed 
dysplastic naevi in 43 (4.9%) of those examined. (32) In another study it
was noted that 1% of 280 non-melanoma control patients had at least 
three clinically atyical naevi. (33) Population based studies suggest that 
sporadic dysplastic naevi occur in 2-5% of the American population. (34) 
A population based study from New Zealand (35) found that 90% of 388 
people in the age groups 30 - 39 and 50 - 59 years had one or more 
dysplastic naevi. The risk of having three or more dysplastic naevi was 
increased 40 fold in individuals with 50 or more banal naevi.
Aside from arguments surrounding the diagnostic features of atypical /  
dysplastic naevi most DNS research has been directed towards clarifying 
their potential for development of MM. Much of the work on MM risk in 
DNS patients has been the result of studies of patients w ith the familial 
syndrome such as that of Greene and colleagues (29). During this study 
401 members of 14 MM prone families were examined. Over a maximum 
of eight years of follow -up 39 MMs occurred in 22 ind iv iduals. 
M elanomas were only seen in family mem bers who them selves had 
clinically dysplastic/ atypical naevi and the probability of MM developing 
in such individuals was calculated as 56% from age 20-59. Such high risk 
individuals are usually recommended to have regular follow-up w ith 
full skin exam ination and photography of naevi if possible. Patients 
usually have either total body or selected area photographs at the time of 
in itial assessm ent. These are available a t the tim e of rev iew  
appointments when new or changing naevi can be noted. Using this type 
of follow-up a group from New York has observed MM developing on 
patients w ith clinically dysplastic naevi. (36) This group followed 452 
people w ith various types of dysplastic naevus syndrome for up to seven 
years. Of the study group, 261 had neither family or personal history of 
MM, 66 had personal histories of MM and 105 were from MM prone
families. During the period of follow-up eighteen MMs were excised, 12 
in-situ and 6 invasive. Of the latter, half (3 MMs) occurred in those w ith 
family histories of MM. All types of DNS patients developed more MMs 
than would be predicted from the observed incidence data for that part of 
USA. Histological evaluation showed that these tum ours occurred in 
contiguity with dysplastic naevi and thus have been interpreted as arising 
from  prev iously  pho tog raphed  dysplastic  naevi. An a lternative  
explanation, however, could be that these lesions were MM from the 
beginning and that the dysplastic lesions are a m arker of increased MM 
risk rather than true precursors. It is well recognised that not all MMs 
seen in DNS patients arise in the dysplastic naevi and that a proportion 
develop on apparently normal skin.
The risk of MM arising in DNS patients with no MM family history is not 
yet clear. Patients with dysplastic naevi and a history of previous MM are 
at an increased risk of a second primary lesion. (37) W hether this risk is 
appreciably higher than the risk of a second primary lesion developing in 
any MM patient remains to be seen. The MM risk for individuals w ith 
clinically a n d / or histologically dysplastic lesions bu t no personal or 
family MM history is probably fairly small but longer follow up may be 
required to clarify this point.
In addition to the relationship with the dysplastic naevus syndrome, MM 
is found in two family cancer syndromes.(38) These are the Lynch Type II 
syndrome and the Li Fraumeni syndrome. In these autosomal dom inant 
syndromes MM occurs in addition to a wide variety of other tumours. In 
add ition  MM accounts for 7% of second m alignancies in fam ilial 
retinoblastom a.
In Britain there is a marked difference in the sex incidence of MM in that 
women develop MMs more frequently than men. (18) Data collected by 
the Scottish Melanoma Group found that in the period 1979-85 MMs 
were twice as frequent in females . In more recent data the female to male 
ratio has fallen to 1.5:1. In high incidence areas like Australia there is no 
difference in the rates between the sexes. The British disparity between 
the sexes led to a search for possible horm onal influences in the 
developm ent of MM. Excised MMs w ere exam ined to see if they 
possessed receptors to hormones and in particular to oestrogen. It was 
noted that only some MMs expressed oestrogen receptors and that this 
occurred in both male and female patients. (39) A proportion of MMs also 
expressed receptors for androgens, progesterone and glucocorticoids. 
From a therapeutic point of view, there was no relationship between the 
presence of oestrogen receptors and the response of secondary MM to 
anti-oestrogen hormone based therapies.
Several groups have tried to assess whether women who have taken the 
oral contraceptive pill have a higher MM rate than those w ho have 
never taken it. The results of the two largest studies suggested that any 
increased risk demonstrated has been small and non-significant. (40,41) In 
both studies there were problems in distinguishing the possible effects of 
oral contraceptive use from other possible aetiological factors such as sun- 
exposure.Another study showed that oral contraceptive users tended to 
have th inner lesions than non-users (42) This d id  not confer any 
improved mortality perhaps due to different site distributions for the two 
groups of women.
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It has been calculated from follow-up data that MM patients have a nine­
fold increased risk of developing a second lesion relative to those with no 
such previous history. (26) This seems to be most likely in the first year 
after initial presentation (43) and in patients aged less than 45 years. Thus 
regular m onitoring w ith full skin exam ination is m andatory  for all 
patients after excision of a cutaneous MM.
Sociological studies have shown that MM occurs preferentially in the 
upper social classes, i.e. professional and "white-collar" workers. (44) Data 
on patients with MM in England and Wales and W ashington State, USA 
was assessed. Patients were allocated to social class groupings as defined 
by the Registrar General. Social class I is professional, II interm ediate 
including commercial and teachers. III skilled workers, IV semi-skilled 
and V unskilled workers. Both incidence and m ortality rates for MM 
were higher in class I and II compared with III, IV and V. Female patients 
had social class assigned on the basis of their spouse's occupation. In 
contrast, the other skin cancers, BCC and SCC are most often seen in 
habitual outdoor workers i.e. mainly class IV and V. (45) It is likely that 
this disparity reflects differences in life-styles among the different classes 
rather than any influence of the occupation itself.
1.3 Aetiology
The w ide variation in incidence of MM w orld w ide is perhaps the 
strongest support for its being, like BCC and SCC, related to chronic sun 
exposure. Areas of high MM incidence like Queensland also have a high 
incidence of BCC and SCC. (1)
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The relationship between chronic UV exposure and MM is not as clear- 
cut as that between UV and BCC or SCC. The skin adjacent to the latter 
tum ours almost always shows histological evidence of actinic (solar) 
dam age. In contrast, however, the skin adjacent to MMs is usually  
histologically norm al, showing no evidence of such dam age. The 
exception to this is the lentigo maligna melanoma type which arises on 
histologically actinically damaged skin.
Several retrospective studies on MM patients have assessed lifetime sun- 
exposure and tried to correlate this w ith MM risk. This has principally 
been done by comparing the cumulative am ounts of sun exposure for 
MM patients with values for non-MM controls. In England and Wales a 
positive correlation was demonstrated betw een hours of sunshine and 
MM incidence rates in different parts of the country. (19) This study 
looked at mean daily hours of sunshine in 14 districts in England and 
Wales. Hours of sunshine and MM incidence rates were gathered over 
similar periods in each district. A correlation was sought between mean 
daily sun and incidence. This study showed that mean incidence and rate 
of secular increase correlated negatively with latitude and positively with 
hours of sunshine. An increasing incidence of MM w ith no significant 
change in hours of sunshine was also observed during the study years. In 
female MM patients the observed correlation suggested an association 
between hours of sunshine in the two year period prior to the calculation 
of the incidence rate.
It has also been suggested that MM development may be related to greater 
than average recreational sun exposure (46) rather than total cumulative 
figures. H olm an and colleagues studied  ou tdoor recreational and
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sunbathing habits in a group of Australian MM patients and showed that 
incidence rates for superficial spreading melanomas were directly related 
to frequency of sun-bathing in young adult life (47) and frequent 
participation in high sun-exposure activities like fishing and boating. 
Such patients had, however, low cumulative outdoor exposure levels. In 
female patients the am ount of skin covered during sun-bathing also 
seemed important. Patients who wore bikinis or who sunbathed naked 
had higher incidences of trunk MMs than those who wore a swim m ing 
costume.
The tim ing of sun-exposure in an ind iv idual’s lifetime m ay be as 
im portant as the amount of that exposure. Evidence from several works 
suggests that sun-exposure in childhood or young adult life may be more 
im portant than that occurring in later life. W ork from A ustralia has 
show n that individuals who move there in childhood acquire that 
country's high MM risk whereas those immigrating as adults keep the 
lower risk of their country of birth. (48) It has been suggested that this 
childhood ultra violet damage may precede a long lag phase prior to the 
development of a melanoma.
Retrospective case control studies suggest that MM patients are m ore 
likely than controls to offer a history of having experienced painful 
sunburns in childhood. English and colleagues interview ed 180 MM 
patients and age and sex matched controls. (49) H istories of painful 
sunburn episodes in childhood years were sought. Positive replies were 
significantly m ore common in the MM group than  in the control 
population. MacKie and Freudenberger (33) interviewed and exam ined 
280 MM patients and age and sex matched controls. They found that
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while 54 (19%) of the MM group gave histories of three or more severe 
sunburns this was the case for only 7 controls. The age at which the 
sunburns occurred did not appear to be significant.
M alignant m elanom as can arise in norm al skin or in pre-existing 
melanocytic naevi. The frequency of the latter occurrence varies from 30- 
70% in different series. (50) These rates are calculated from histological 
studies of excised MMs (51) or from MM patient's histories of pre-existing 
lesions. G iven the ub iquitous na tu re  of the com m on, acquired  
melanocytic naevus and the rarity of MM it is obvious that a very small 
proportion of these naevi develop into MM. The recently published UK 
mole study (52) found that the prevalence of benign naevi increased 
betw een the ages 4 and 11. Moles were more frequent in boys and in 
w hite  children than in non-w hite children. They w ere also m ore 
frequent in poor tanners, individuals w ith freckles, individuals w ith a 
history of sunburn and those individuals w ith a history of a num ber of 
foreign holidays.
Some studies have suggested that people with large numbers of clinically 
benign naevi are at higher risk of MM. (53) These workers perform ed 
naevus counts on 180 MM patients and 197 non-MM controls. Naevi 
were diagnosed solely on clinical grounds and all sites except the scalp 
and genitalia were counted. Only naevi more than two m illimetres in 
diameter were included and these were clinically designated as " benign" 
or "atypical". This study demonstrated a twelve-fold increased MM risk 
in individuals with more than 50 benign naevi compared to individuals 
w ith fewer benign naevi. Another w ork w ith  a sim ilar design from 
Australia counted only palpable naevi on the arms of MM and control
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patients. (48) These workers also showed that MM patients tended to 
have greater numbers of naevi than the control group.
Two other types of pigmented naevi have been noted to be related to a 
higher risk of MM than the common acquired type. These are the 
dysplastic naevus (v.s.) and the giant congenital naevus. This latter rare 
type of naevus occurs in less than 0.1% of Caucasian neonates (54) and 
may be associated w ith diffuse meningeal melanosis. In general the size 
and site of these naevi preclude their prophylactic excision. Thus clinical 
m onitoring of the lesion w ith or w ithout photography is the usual 
m ethod of follow-up employed. Clinically, due to their characteristically 
irregular p igm entation  and texture, developm ent of MM m ay be 
detectable only at a comparatively late stage. It has been reported that such 
giant congenital naevi have an estimated lifetime risk of MM of 6%. (54) 
In half of another series of cases of MM arising in childhood there was a 
predisposing cause such as a giant congenital naevus. (55) It has also been 
suggested that small and medium sized congenital lesions m ay evolve 
into MM. A study of MMs by Rhodes and colleagues noted  the 
histological evidence of small congenital naevi contiguous w ith  the 
tum ours far more frequently than would be expected by chance. They felt 
that this observation supported the role of the small congenital naevus as 
a true precursor of melanoma. (56) In a retrospective study of patients 
aged < 30 at presentation Mackie found that 44% of MM arose on small 
early onset naevi (57)i.e. those present before the age of two years.
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1.4 Types of MM
There are four main histological types of MM and these can usually also 
be distinguished on clinical grounds from each other. The most common 
variety is the superficial, spreading MM (SSM) which constitutes 50-60% 
of British series of MMs.(58) It consists of a brown-black lesion usually 
more than  7mm in diam eter. Characteristically it has an irregular, 
scalloped border and a variable am ount of pigm entation throughout. 
Initially SSMs are flat and may remain so for a period of months or years 
increasing in area but not in depth. Histologically at this stage ,tum our 
cells are confined to the derm o-epiderm al junction. This interval is 
termed the radial growth phase during which it is has been argued that 
lesions have no potential for metastasis.(59) This phase may be followed 
by a vertical grow th phase which is characterised clinically by the 
appearance of a palpable nodule. Histologically, this macroscopic change 
in the lesion is associated with invasion of tum our cells into the dermis 
sometimes including its lymphatic and blood vessels. At this stage the 
MM is regarded as having at least a potential metastatic capacity. The 
duration, according to the patient's history, of each of these intervals may 
be variable. The radial phase may be of a few months to several years in 
duration while patients usually present w ithin several m onths of the 
nodule's appearance (vertical growth phase).
The second most common variety is the nodular MM constituting 15- 
20% of m ost British series. In this variety  there is no clinically 
recognisable radial grow th phase. These lesions usually grow over a 
period of a few months rather than years and not infrequently their 
surface is ulcerated. Thus this type of MM may present w ith bleeding.
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These lesions may be quite deeply pigm ented w hen they may closely 
resemble vascular tumours or they may be amelanotic.
Lentigo m aligna m elanomas (LMMs) com prise 10-15% of MMs. This 
variety has most in common with BCCs and SCCs in that it occurs on 
chronically sun-exposed sites usually in patients aged over 60. The 
history is usually of an extremely prolonged radial growth phase of many 
years duration during which the lesion is term ed a lentigo maligna (in- 
situ melanoma). As is the case in the superficial spreading variety the 
invasive, vertical growth phase is heralded by the appearance of a nodule.
The least common variety of MM encountered in British series is the 
acral-lentiginous melanoma (ALM). This occurs on the palms, soles, sub­
ungual areas and on mucosal surfaces. Perhaps due to the relative 
invisibility of such sites this variety not infrequently presents at a more 
advanced stage than the other types. Acral melanomas constitute about 
5% of British series. Interestingly, however, this variety constitutes a 
significant proportion of the small num ber of MMs seen in Negro and 
oriental races.(60) In a study of 187 melanomas in Japan more than 90% of 
p lantar and sub-ungual lesions were of the ALM variety. The site 
distribution of MMs in this group was totally different to that observed 
among white populations. In the Japanese study 32.1% of lesions occurred 
on the sole and 6.4% were sub-ungual in location. The reason for these 
differences is not clear and certainly would not be explicable in terms of 
sun-exposure. In contrast, the Scottish Melanoma Group data (18) noted a 
subungual location in 3.7% of male m elanom a patients and 2.5% of 
female patients. 5.6% of male MMs and 5.4% of female MMs occurred on 
the feet.
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1.5 Site of melanoma
MM can occur on any part of the body including areas never exposed to 
UV light eg the perineum. (61) While MMs in general do not show the 
clear cut relationship to chronic sun-exposure demonstrated by studies of 
squamous and basal cell carcinomas, one study from Canada has show n 
that if their incidence is expressed per unit area of skin MMs do occur 
more frequently on exposed sites like the face rather than on habitually 
covered sites.(62)
There is a difference in site distribution of MM between the sexes. The 
m ost common site for wom en is the lower leg (41.8%) and the trunk  
(37.4%) for men (18),(SMG data). Workers in Denmark have observed a 
change in sex-specific sites of MM in recent decades.(63) There has been a 
marked increase in MM of the trunk in women aged less than 40 years of 
age. The authors felt that this change m ight reflect the com paratively 
recent tendency to expose more of the trunk during sun-bathing. This 
observation confirms that of Holman who noted a relationship between 
types of swimwear worn by female MM patients. Those who wore bikinis 
or no swimwear at all had a higher incidence of truncal MM. (47)
1.6 Prognostic features
The main factor which helps predict the prognosis of a MM is its depth of 
invasion into the dermis. This is termed the Breslow thickness and is 
defined as the distance in millimetres from the granular layer of the skin 
to the deepest invasive MM cell. (64) In the original description thickness 
w as show n to correlate d irectly  w ith  poor p rognosis. Breslow 
m easurem ents are made w ith a micrometer and w hilst both inter and
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intra-observer variation in values has been observed the error seems 
small. In one study, (65), sections of 50 "thin" MMs were reviewed by 
three independen t pathologists. For Breslow m easurem ents in tra- 
observer variation of 74-88% was seen and inter- observer was 82-88% if 
two measurements were taken by each observer.
In Scottish Melanoma Group data, MMs are grouped into three thickness 
categories; "thin" < 1 .5  mm, "intermediate " 1.5 -3.49 mm and "thick" >
3.5 mm. In agreement with Breslow's initial observation, (v.s.) thickness 
relates directly to poor prognosis for Scottish patients. The thicker the 
melanoma the more likely it is to recur and /  or metastasise. Thus, thicker 
lesions contribute to MM mortality as well as morbidity. A recent study 
from Scotland reported 5 year survival rates for thin, intermediate and 
thick lesions as 92.5%, 72.6% and 48% respectively.(18)
In addition to the above objective m easure of thickness, the level to 
w hich  the MM has invaded into the derm is is also im portan t 
prognostically. This depth is termed the Clark level and is categorised 
into 5 groupings.(Figure 1). In many pathology laboratories, both Breslow 
and Clark readings are made and are interpreted in conjunction w ith 
each other. Perhaps due to the more subjective nature of the Clark 
assessment, the observed variation betw een Clark levels was 60% in 
Holloby's study.(65)
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Figure 1: Clark Levels
Level 1; Melanoma cells within the epidermis only.
Level 2; Melanoma cells encroaching on the papillary
dermis.
Level 3; Melanoma cells filling the papillary dermis.
Level 4; Melanoma cells entering the reticular dermis.
Level 5; Melanoma cells invading the subcutaneous fat.
It has been suggested based on the results of several studies that various 
other clinical and pathological features of MM confer prognostic 
significance. These studies have all been perform ed by retrospectively 
assessing clinical and histological features of MMs and relating these to 
prognostic measures such as survival rates and / or disease free intervals. 
The clinical features assessed include site, area, ulceration, sex and history 
of previous naevus. From a histological point of view, the effect of cell 
type, mitotic rate, presence of a naevus or an inflammatory response and 
evidence of lesion regression have been assessed. Most series agree that 
low Breslow thickness and female sex confer a better prognosis. In a series 
published by Blois and colleagues the association between survival and 
tum our depth, histological type, sex, age and site was assessed in 1123 
MM patien ts.(66) In addition to beneficial effects of low Breslow 
measurements and female sex on prognosis this group observed poorer 
survival rates for lesions arising on the head and neck compared to all 
other sites. This site effect was still significant after correcting for 
thickness. In a similar study of 262 patients, however, Johnson failed to 
demonstrate any influence of site on prognosis that was independent of
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the Breslow thickness.(67) In this work prognosis was assessed in terms of 
survival time, recurrence free time and 5 year recurrence free rate. Once 
again female sex was associated with improved prognosis after correction 
for Breslow thickness. Other than thickness and sex no variable had a 
significant effect on survival time. However, Clark level was significant 
for 5 year survival rate, num ber of mitoses, regression and vascular 
invasion for recurrence free time and vascular invasion and mitotic rate 
for recurrence free time. The most recently published study of this type 
looked at tw enty three factors in 264 patients w ith  melanoma. (68) 
Prognosis was based on survival over an eight year period of follow-up. 
M ulti variate analysis identified six factors w hich had  prognostic 
significance independent of each other. These were mitotic rate, tum our 
infiltrating lymphocytes, thickness, site, sex and histologic regression. 
When a logistic regression model correcting for thickness was used the 
other five variables were still found to be independent predictors of 8 year 
survival.
This work by Clark suggested that lesions on the BANS areas ie on the 
back, posterior arms, posterior neck and scalp have a worse prognosis 
than other sites even when corrected for Breslow thickness. Other series 
have also looked at the possible influence of site on prognosis. In a series 
of three articles Day has looked at prognostic factors in patients w ith 
"thin", "intermediate" and "thick " lesions. In this w ork th in  was 
classified as Breslow of 0.76 -1.69mm, intermediate as 1.51-3.99mm and 
thick as > 3.65mm. Eleven of the twelve deaths which occurred in the 203 
patients w ith thin lesions occurred in those with lesions in the BANS 
sites. The only other useful prognostic factor identified for this group was 
the Clark level.(69) For patients with intermediate and thick lesions Cox's
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multivariate analysis of variables was used to identify the combination of 
variables best able to predict the likelihood of bony or visceral métastasés. 
In the 177 patients in the intermediate group these were more than 6 
mitoses per mm2, location other than forearm or leg, ulceration w idth> 
3mm and the presence of microscopic satellite lesions.(70) In the 77 
patients w ith thick tum ours the four factors w ere absen t/m in im al 
lymphocytic response at the base of the lesion, histological type other 
than SSM, location on trunk and presence of involved draining lym ph 
nodes.(71)
There was previously some confusion in MM literature as to the effect of 
pregnancy on MM behaviour. Some studies suggested that MM arising in 
pregnancy carried a worse prognosis. (72) This led to further speculation 
as to a hormonal influence on MM. (v.s.) From a m anagem ent point of 
view it used to be suggested that MM patien ts avoid subsequent 
pregnancy lest this pre-dispose to recurrent disease. Reintgen and 
colleagues showed that while intercurrent pregnancy conferred a worse 
than predicted prognosis, subsequent pregnancy had no effect on 
recurrence rate or survival.(73) This group looked at 58 wom en whose 
m elanomas arose during pregnancy and at 43 who became pregnant 
w ithin 5 years of melanom a developm ent. These indiv iduals w ere 
m atched for age, sex, site and stage of prim ary lesion, C lark level, 
thickness, ulceration and histologic type w ith patients selected from the 
melanoma register at the same medical centre. A recent WHO study has 
looked at a total of 388 women who developed melanoma before, during, 
betw een or after pregnancies.(74) The group whose tum ours w ere 
diagnosed whilst they were pregnant had tum ours of greater thickness 
than the other three groups. After controlling for Breslow thickness.
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however, there was no significant difference observed between survival 
rates for all the groups.
1.7 MM M anagement
In most instances prim ary MMs are managed initially by surgical means. 
The size and site of the tum our dictates the complexity of the surgery 
required. Large lesions may require the use of skin grafting or other more 
complex surgical techniques. However, lesions of l-2cm in diameter can 
usually be excised w ith a 0.5-lcm m argin of norm al skin and prim ary 
closure achieved. Older MM literature suggested that w ide excision (3- 
5cm of adjacent norm al skin) was required to reduce the chances of 
subsequent recurrence. (75) More recent evidence from follow-up studies 
has shown that this type of m anagement did not confer any advantage 
over narrow er (1cm) margins. Breslow and Macht reviewed excision 
m argins of 62 th in  m elanom as processed in their laboratory .(76) 
Measurements were taken from pathology reports i.e. from fixed tissue 
which are likely to be significantly smaller than those from fresh tissue. It 
was found that although margins varied from 0.1- 5.15cm in this group 
no patient had developed recurrent disease. In an international study 
Veronesi looked at two comparable groups of MM patients. 305 patients 
had narrow  excisions w ith a 1 cm margin around the lesion while the 
other group of 307 patients had lesions excised with a margin of 3 cms or 
more. No difference was found between the two groups in the metastatic 
rate to regional lymph nodes or to distant organs. Disease-free survival 
rates were similar for both groups. (77)
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If MM spreads to regional lymph nodes the initial treatm ent is surgical, 
w here feasible. In m ost centres clearance of the regional nodes is 
performed rather than biopsy of macroscopically involved ones. For limb 
lesions the place of prophylactic excision of draining lym ph nodes has 
been the subject of m uch argum ent. In a WHO m ulti- centre study 
Veronesi prospectively random ised 267 melanoma patients to elective 
lym ph node dissection while 286 patients had dissection perform ed only 
w hen there was clinical evidence that the nodes were involved. After a 
follow-up period of up to seven years there was no evidence of any 
difference in out-come between the two groups. (78)
It is recognised that MM may have a somewhat unpredictable course with 
secondary lesions being reported more than 10 apparently disease free 
years after excision of the primary lesion.(79) Another group looked at 13 
patients with thick MMs (> 5.5 mm) who survived longer than 10 years 
and compared them with 13 age, sex and treatment matched patients also 
w ith thick (> 5.5 mm) MMs w ho died w ithin 5 years. There was no 
difference in Clark level, ulceration, m itotic rate or inflam m atory  
response between the two groups. (80) In contrast, Shaw's group (81) 
followed 846 patients w ith MM < 0.76 mm for 2 to 31 years. 61 patients 
(7.2%) had recurrence, mainly to regional lymph nodes. This was more 
likely w ith axial, especially scalp, primaries than w ith limb prim aries. 
Metastatic spread was also associated with ulceration, high mitotic rate 
and deeper Clark level (III and IV compared w ith II). In general most 
MMs metastasise within the first two years of follow-up. (43) A m easure 
called the hazard rate analysis has been em ployed to p red ic t the 
probability of death from MM in a group of 719 MM patients. (82) It was 
found that the peak hazard rate was at the 48th m onth of follow-up for
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the group as a whole. If, however, the group wa_s divided into thickness 
categories thicker lesions peaked at month 40 and thinner ones not until 
the 72nd. Many clinicians feel that lifelong follow-up may be necessary 
for MM patients in order to detect recurrent disease, metastatic disease or 
further prim ary lesions.
Once major organs like liver, lung and bone are involved chemotherapy 
may be used. Large numbers of chemotherapy regimens have been used 
and m any more are under current evaluation. The use of various 
regimens in patients with disseminated melanoma has been reviewed by 
Bellet. (83) The single most effective chemotherapeutic agent was DTIC 
(dacarbazine) w hich produced a combined response rate of 23.4%. 
Combined response was classified as complete response or at least 50% 
reduction of m easurable tum our bulk. In addition to single drugs, 
various combinations of chemotherapy regimens have been used. These 
give combined response rates of 0-48% with generally very low complete 
response rates. In some series, response rates include patients w ith sub­
cutaneous m etastatic disease only. If this latter, generally responsive 
group are removed the responses for true visceral disease are very low 
indeed. The combination of DTIC and Tamoxifen has been used in the 
light of a possible endocrine influence on MM (v.s.). This was found to be 
more effective than DTIC alone in women while male patients showed 
no such benefit. (84)
Patients with metastatic disease confined to one limb may also be offered 
isolated limb perfusion. This allows the use of higher concentrations of 
chem otherapeutic agents w ith in  the affected limb only and avoids 
systemic toxicity. The most effective drug to be used in this w ay is the
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alkylating agent melphelan. In all reported series this technique produces 
m arked reduction of localised recurrent disease including 'in-transit' 
métastasés. (85) Unfortunately it is difficult to assess the value of this 
treatm ent more fully as the results are usually expressed as 5 year 
survival figures without figures for a matched, untreated control group.
Many textbooks say that melanoma is a radio-resistant tumour. There is, 
however, evidence from several studies that it can be useful in treatm ent 
and palliation of disease. Radiotherapy has been employed as the prim ary 
therapy in lentigo malignas and lentigo maligna melanomas. H arw ood 
described his experience of this using four or five fractions over four to 
five weeks, a protocol similar to that used for treating other skin cancers. 
In his series 28 patients with lentigo maligna melanoma were treated and 
followed up for periods of 6 months to 8 years. Twenty two patients were 
disease free, 1 patient was alive with metastatic disease, 2 had residual /  
recurren t local disease and inform ation w as not available on the 
rem aining three patients. (86) Responses have also been described for 
tum ours treated  concom itantly  ' w ith  surgery and rad io therapy . 
Obviously in these instances it is impossible to separate the effects of the 
two treatm ent modalities. Perhaps the most frequent use of radiotherapy 
is in palliation of metastatic lesions especially cerebral ones. In a review 
article of published series Young noted response rates of 50% for bony 
lesions and 67% for cerebral ones. (87)
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CHAPTER TWO
CURRENT PROBLEMS IN MELANOMA RESEARCH
2.1 Changes in incidence
2.1.1 W orldwide
The most striking feature of melanoma epidemiology in recent years has 
been the rapidity with which its incidence has risen world wide. In the 
USA, rates for male and female MM incidences rose by 296% and 189% 
respectively in the period 1950- 1985. (88) This study examined incidence 
and mortality rates for a wide variety of cancers w ithin USA. W orkers 
observed significant rises in incidence and mortality rates of four cancers 
during these years: lung cancer, melanoma, multiple myeloma and non- 
Hodgkins lymphoma. The observed rise in male lung cancer was less 
than that of male MM while that for female MM was surpassed by female 
lung cancer and m ultiple myeloma. A lthough other forms of cancer 
show ed increases in incidence, albeit sm aller than  these four, the 
mortality rates for the other types were either static or falling. Another 
American study of a population contributing to a single health plan 
showed a 3.5 fold and 4.6 fold increase in MM incidence for m en and 
women respectively between 1960 and 1986.(89) Data from the national 
SEER (Surveillance, Epidemiology and End-Result) program  for the 
period 1973-87 reports 4.8% per annum and 3.6% per armum increases in 
MM incidence for American men and wom en respectively. M ortality
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rates were not rising so sharply w ith increases of only 2.5% and 1.3% 
respectively being noted.(90)
It has been estimated that were this currently observed trend tow ards 
increasing MM incidence to continue, by the year 2000 1% of all 
Americans would develop MM during their lifetime. (91)
In Scandinavia there has been a doubling of MM incidence in the past 
decade. (21) Rauh et al (92) reported a 5 fold rise in incidence of MM in 
Germany between 1970 and 1984. Danish workers have also demonstrated 
a rise in trunk MMs especially in women during the period 1943-82. (63) 
The study reported by Glass also demonstrated a specific increase in trunk 
MMs in both sexes (89) while rates for head and neck tum ours were 
largely unchanged.
An apparent rise in the incidence of any disease may result from changes 
in diagnostic criteria or from improved collection of data. It is recognised 
in the interpretation of all MM data that there m ay be inter-centre 
variability in reporting m ethods and that these m ethods m ay alter 
through time. A group of workers from Bristol took part in a study to 
investigate the latter possibility further. (93) A selection of benign and 
malignant pigmented lesions were identified from files for three separate 
time periods, 1945-49, 1954-57 and 1980. New slides were cut from the 
stored paraffin blocks and then re-examined "blind" by two pathologists. 
The lesions were first categorised as benign or m alignant then a more 
detailed diagnosis was reached. The original and reviewed diagnoses 
w ere compared. Of a total of 210 lesions examined only twenty-two were 
reclassified and the changes in interpretation of the slides was defined as
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minor in eighteen. One case on review was interpreted as m alignant 
instead of benign while three cases originally categorised as m alignant 
were re-assigned to the benign group. Half of the changed diagnoses 
related to the oldest group of specimens (1945-9). Assuming that this 
extremely low rate of major disagreement w ith the original diagnosis 
would occur in most pathology departm ents it was concluded that the 
observed changes in MM incidence were unlikely to be explained solely 
by changing reporting habits. In another study from Australia, 761 MMs, 
both in-situ and invasive, were reviewed by a panel of six pathologists. 
Various param eters including Breslow thickness, Clark level, regression 
and mitotic activity were scored. High levels of agreement were found for 
Breslow m easurem ent and ulceration and intermediate levels for Clark 
level, histological type, presence of pre-existing naevus, solar elastosis 
and determ ination of cross sectional profile of the lesion. All other 
param eters show ed poor agreem ent. (94) There was, how ever, no 
disagreement with the diagnosis of MM. Thus, on the basis of these two 
studies and perhaps more importantly given the sheer size of the present 
changes in MM data it seems that differences in diagnostic categorisation 
played only a small role in explaining the recent incidence rates. No 
series reports any change in the proportions of the different histological 
types of MM or in the observed frequency of any specific pathological 
features.
In many series of MMs data is collected through national cancer registries. 
Little information exists on the accuracy of such systems although one 
American study found that reported cases of all cancers were w ithin 5% 
of actual cases. (95) Actual cases were calculated from histological
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diagnoses obtained  from pathology departm ents. In the sta te  of 
Massachusetts, a comparison was made between the national figures and 
independently collected data for MM (96) in the period 1982-1986. It was 
estimated that during this time at least 12% of histologically confirmed 
MMs were not registered in the national figures. It is possible therefore, 
that recent rises in MM incidence based on national cancer data m ay well 
be an under-estimate of the true extent of the problem.
2.1.2 Scotland
Data collected by the Scottish Melanoma Group (SMG) showed a 7.4% 
annual increase in MM incidence (18) over the 11 year period 1979-1989. 
The figures for 1979-83 are given in Table 1 and more recent data from 
this group for the years 1984-1990 appears in Tables 5:16 - 5:20.
The Scottish Melanoma Group estimate that they register 95% of all MMs 
treated in private and NHS hospitals within Scotland. This high level of 
accuracy is partly due to the small number of individuals involved in the 
collection of data ie pathologists, dermatologists and plastic surgeons in 
Scotland. (SMG data) Hopefully this means that the Scottish figures are as 
accurate as possible.
2.1.3 Reasons for Changing Incidence
If it is accepted that the observed rise in MM occurrence is real it is 
appropriate to consider the possible causes of this at an early stage. 
Assessment of current information on MM aetiology suggests that the 
most consistent association is w ith ultraviolet exposure. The w ide 
variation of incidence w ith latitude and the relationship to susceptible
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skin types lends support to this. Melanoma does not, however, share the 
direct relationship w ith chronic sun  exposure exhibited by basal and 
squamous cell carcinomas. It is suggested that intermittent bursts of sun- 
exposure m ay be more im portant for melanom a. This theory w ould 
support the observed link betw een high incidence MM and indoor 
occupations.(44) Attention has also been directed to the question of w hen 
this interm ittent sun exposure took place. A case-control study from 
Australia (47) looked at both recreational and occupational sun exposure 
in early life and in the 10 years before diagnosis. Information was also 
collected on the frequency of sunbathing between the ages of 15 and 24, an 
interval w hen sunbathing is m ost common. The authors noted that 
individuals with low total outdoor exposure in early life had an increased 
incidence of SSMs. The rate of SSMs of the trunk was related to frequency 
of sunbathing in both sexes and indeed in women was greater for those 
wearing bikinis compared to swim-suits. A change in the pattern  of site 
involvement in melanoma has also been reported from Denmark where 
the observed rise in female trunk lesion has being linked to the fashion 
for two piece swimwear. (63) Glass (89) has also noted a rise in trunk 
MMs in recent years.
For Caucasian patients the part of the world where pre-teenage years are 
spent seems to determ ine that individual's lifetime MM risk. People 
emigrating to Australia after childhood do not appear to acquire that 
country's high MM risk.(48) Native born Australians have higher MM 
m ortality rates than im m igrants. For the latter, how ever, m ortality 
increases w ith length of residence in Australia.(97) Likewise, immigrants 
to Israel keep the risk of their country of origin. Those from Europe and
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America have higher and those from Asia and Africa lower risks 
compared to native Israelis.(98)
Two explanations have been proffered for possible recent changes in sun- 
exposure, namely a behavioural one reflecting the fashion for high 
exposure sports and sun-tans and an environm ental one in which the 
amount of energy from the sun reaching earth has risen.
The link between MM incidence and changing recreational habits could 
be the explanation for the "cohort effect" noted in melanoma literature. If 
MM patients are studied grouped according to year of birth, higher rates 
of MM emerge as successive generations reach the same age group. This 
trend has been observed in several countries of both high and low 
incidence.(99) A study of birth cohorts in Australia showed an increasing 
incidence starting with those born in 1865 and stabilizing around the 1935 
cohort. (14) The cohort effect has been interpreted as being a reflection of 
the fashion for exposing more skin to the sun and increased availability 
of sunny holidays in successive generations. Cohort analysis can also be 
applied to mortality data. There has been a trend to increasing mortality 
with successive birth cohorts but the rate of increase appears to be slowing 
in recent years. (100)
An alternative explanation for changing MM trends is that more harmful 
u ltra violet light is now  able to reach earth  due to environm ental 
changes. Ultra violet light is divided into UVA, UVB and UVC w ith 
wavelengths of 320-400nm, 290-320 and 200-290 respectively. The most 
widely publicised recent environm ental change affecting ultra-violet 
light is the thinning of the protective ozone layer of the stratosphere.
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Ozone is formed by the action of ultraviolet light on oxygen atoms. This 
process occurs very slowly and thus damage to the ozone layer may take 
many years to be reversed. The ozone layer protects the earth's surface 
from ultraviolet light, virtually blocking the very harm ful UVC rays. 
UVC is maximally absorbed by DNA while this occurs to a very much 
lesser degree w ith UVB and hardly at all with UVA. Thus the potential 
for damage w ith UVC is considerable. Theoretically, a dam aged ozone 
layer would allow more ultraviolet light to reach m ore people and 
eventuate in more MMs.
Scientists first reported a "hole" in the ozone layer over Antarctica in 
1984 and thinning of the layer has been noted in other parts of the world 
subsequently. This thinning is maximal in the northern  hem isphere 
between latitudes 50-60.(101) The chemicals which cause most damage to 
the ozone layer are chlorofluorocarbons produced by aerosols and 
refrigerants. The w idespread use of these products has increased in the 
last few decades.
On a related theme, it had previously been noted that peaks of increase in 
MM incidence m irrored the cycle of "sunspot" activity.(102) Sunspots 
occur in peaks approxim ately every ten years and can catalyse the 
destruction of ozone.! Peaks in  MM incidence fo llow ed 2 - 3  
years after sunspot peaks w hile no sim ilar cyclic pa ttern  was 
no ted  for o ther types o f  tumour. The recen t observation  o f  
reduced  ground level u ltrav io le t m easurem ents associated  w ith 
sunspots m ust cast doubts on the direct rela tionsh ip  to MM.
It is likely that the increase in MM incidence is a reflection of the \ 
combination o f behavioural change and environmental differences and ;
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thus both w ould need to be addressed in any attem pt to reverse this 
trend.
2.2 Prognosis in Melanoma
2.2.1 General Comments
As mentioned previously the most important prognostic factor for MM is 
the Breslow thickness. Thick prim ary tum ours are m ore likely to 
m etastasise than thinner lesions. Thus the proportion of a country 's 
MMs in the thick, poor prognosis category is reflected in that country's 
overall MM mortality rate. If the overall incidence of MM rises and the 
proportion of poor prognosis lesions rem ains the same, in tim e the 
mortality rate from MM will increase in parallel.
Data from A ustralia, (13) has show n that m ortality rates are not 
increasing in line with incidence. This would seem to be explained by the 
fact that the proportion of thin, good prognosis lesions has increased to 
the extent that the vast majority of prim ary lesions are now in this 
category. It has been suggested that this change is a result of a long 
running public education campaign to encourage earlier diagnosis and 
treatment. (103, 104)
2.2.2 Scotland
In the period 1978-83 Scottish patients with newly diagnosed primary MM 
had a poor overall prognosis with a 62% 5 year survival rate. (105) This 
com pared unfavourably  w ith  data from  other countries notably  
Australia. (13) In Australia 62% of MM patients presented w ith thin 
tum ours and their overall 5 year survival rate was 80%. This difference
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could relate either to different biological behaviour of the tum our in 
different parts of the world or could reflect presentation of MM at a later 
stage in Scotland.
The Scottish Melanoma Group arbitrarily divides reported melanomas 
into three thickness categories according to the Breslow measurement of 
the prim ary lesions. These are "thin" 0-1.49mm, "intermediate" 1.5-3.49 
mm and "thick" >  3.5mm. The 5 year survival figures for patients 
presenting up to 1983 were 93%, 67% and 37% respectively.(105) The poor 
overall survival rate of only 62% reflects the high proportion  of 
individuals in the thick and intermediate categories.
During the years examined in the above study the percentages of Scottish 
patients presenting with thick lesions was 31, w ith intermediate 30 and 
w ith thin lesions only 39. In an attem pt to explain the d isparity  in 
num bers of thick lesions in Scottish patients com pared to A ustralian 
ones a search for possible delay in diagnosis in the Scottish cases was 
undertaken.
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Table 1: Numbers  of  melanomas in Scotland
Year T hin
Tum our thickness 
Interm ediate Thick Missing Total
1979 92 78 81 0 251
1980 105 62 69 16 252
1981 81 66 79 13 239
1982 99 71 82 16 268
1983 117 96 81 14 308
Total 494 373 392 59 1318
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2.3 Delay in Diagnosis
2.3.1 General
It seems logical to assume that the earlier a correct diagnosis is m ade and 
appropriate treatm ent instituted for any malignant condition, the better 
the outlook for the patient. Thus "delay" in diagnosis is generally 
thought to be disadvantageous although very little w ork correlating 
delay to outcome has been carried out.(v.i.)
There is no clear definition of delay as, other than in those patients 
whose tum ours present as incidental findings all patients have some 
interval between noting the abnormality and seeking advice about it. The 
early work of Pack and Gallo (106) defined "delay" as a period of greater 
than three months between noting a new symptom or sign and seeking 
medical advice about it. This time interval has become widely accepted as 
a reasonable definition of delay.
The w ord "delay" unfortunately implies some fault on behalf of the 
doctor or the patient. One group has advised that the term  "delay" be 
avoided and "lagtime" substituted. (107) These workers interviewed 125 
indiv iduals w ith recently diagnosed malignancies including MM and 
(enquired about lagtime to diagnosis. Patients were then subjected to 
(extensive psychological testing. Individuals with longer lagtimes tended 
ito deny their disease, to believe it was not serious and to have more 
m arital and family problems than those with shorter lagtimes. However, 
(Only in those with breast cancer did the duration of lagtime correlate with
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the stage of the tum our at the time of presentation. A previous study, 
having shown that 62% of cancer patients waited more than 3 m onths to 
seek medical advice interviewed 314 patients about their reasons for 
delay. (108) These patients had breast, cervical, m outh or skin cancer (MM 
or SCC). The authors found that while m ost breast cancer patients 
suspected they had cancer before seeing their doctor, patients w ith the 
other types of tum our were largely ignorant of the significance of their 
symptoms. Over half of all the patients interview ed delayed seeking 
medical advice for at least three months. Delays were longer among those 
who suspected they might have cancer.
A study of delay in cancer patients in New Mexico looked at 800 
individuals w ith all types of cancer. The most frequently encountered 
tum ours w ere those of the co lon/rectum , prosta te  and breast. The 
investigators assessed several medical and sociological factors including 
the site, ethnic group, social class, and knowledge of cancer. They found 
that 20% of the patients delayed for at least 3 months. Delays were greatest 
for cancer of the prostate and least for breast cancer. Hispanic patients 
delayed more than non-Hispanics and patients w ho did not attend a 
physician for regular check-ups were also more likely to delay. (109)
Adam and colleagues also looked at possible delay in a group of 162 
women with newly diagnosed breast cancer.(llO) They considered delay 
to be composed of three intervals between four events; (i) patient noting 
the abnormality, (ii) consulting their general practitioner, (iii) referral to a 
specialist and (iv) definitive treatment. Any interval of greater than two 
weeks was considered as a delay. In their study they found that 80% of the 
patients had at least one "delay" interval. Patient- attributable delay was
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due to failure to appreciate the potential significance of their symptoms 
in 44% of cases and to rationalisation of symptoms or domestic problems 
in a further 30%. Another study of delay in breast cancer patients (111) 
involved interviewing 145 patients. Those presenting w ith a breast lump 
alone or accompanied by other signs or sym ptom s had significantly 
shorter patient- attributable delays than those w ith other, less well- 
recognised presenting features.
The presence and influence of delay in diagnosis of testicular tum ours 
has also been studied. Patient-attributable delay of more than three 
months was associated with a later stage at diagnosis. (114) Another group 
found that 93% of patients presenting w ith in  1 m onth of noting 
symptoms had Stage 1 disease only while 50% of those delaying more 
than 6 months had clinically detectable metastatic disease.(115) A further 
study of Irish patients w ith testicular tum ours show ed that delay 
correlated w ith presentation with métastasés, decreased prospects of cure 
and increased mortality. (116)
2.3.2 Delay in West of Scotland Melanoma patients (117)
A group of 125 patients presenting with prim ary melanoma was studied 
to establish the presence or absence of delay. Possible delay was recognised 
at these time points; (i) the patient could delay in seeking the advice of 
their general practitioner about a suspicious pigm ented lesion, (ii) the 
general practitioner could delay in referring the patient for specialist 
opinion and (iii) there could be a hospital delay either in seeing the 
patient on receipt of the general practitioner's letter or in instituting 
therapy. These intervals were termed patient, general practitioner and
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hospital delay respectively. They were added together to establish the 
duration of total delay. Combined durations of three months or more 
were classified as "delays" in this study. The dates used to calculate the 
delays were obtained from a questionnaire completed by the patients and 
confirmed using the hospital records and referral letters. The patien t 
questionnaire covered m any different points in the patien t's past 
m edical, occupational and social histories and was not confined to 
possible delay alone. Full details of the the patient's age and sex together 
with the site, histological type, Breslow thickness and other pathological 
features of the melanomas were available from the SMG proformae.
The study patients consisted of 88 women and 37 men (f:m:2.4:l) of ages 
ranging from 19-82 years. Of the 125 evaluable patients only twenty (16%) 
had total delays of less than three months. Sixty patients (50%) had delays 
of three to twelve months and forty two (34%) of more than a year. When 
the individual components of the delays were examined it was found 
that there were no hospital delays of more than three weeks. In three 
cases (2%) the general practitioner had delayed referring their patients to 
hospital for six, eight and sixteen weeks respectively. In all these 
instances, however, the patient had delayed for more than three months 
before seeking their general practitioner's advice. Thus in 102 of the 125 
cases where the total delay had been over three months delay was entirely 
attributable to the patient. No significant delays were due solely to the 
general practitioner or the hospital service.
Ninety nine of the 105 delay patients (94%) said that they had not sought 
advice earlier as they had been totally unaw are of the po ten tial 
seriousness of their suspicious pigmented lesion. Four patients (4%) cited
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other seemingly more important family reasons for the delay while two 
patients (2%) adm itted that they feared the surgery that m ight ensue if 
they sought medical advice.
There was no significant difference in the mean age at presentation in 
those with and without delays. The mean age of those waiting less than 3 
months was 47 years (range 19-71), for those waiting 3-12 months 48 years 
(22-79) and for those waiting more than 12 months 52 years (29-82)
The site of the prim ary lesion was designated "socially visible" or 
"usually covered". Socially visible sites were the face, neck, hands and 
female lower leg. Sites were examined in this w ay to see if ease of 
observation of the melanoma by the patient and others lead to earlier 
presentation. No significant differences were dem onstrated in the mean 
delays for covered and socially visible sites. Likewise there was no 
significant difference in the mean delays for m en and wom en patients 
nor any variation according to the histological type.
The Scottish study thus demonstrated three findings; (i) there was a delay 
in diagnosis in the m ajority of patients, (ii) alm ost all delays w ere 
attributable to the patient and not the general practitioner or the hospital 
service and (iii) patient delay was almost always due to lack of knowledge.
Relatively few studies have specifically addressed the problem of delayed 
diagnosis of melanoma. Temoshok and colleagues (118) studied patient- 
attributable delay in 106 patients looking at behavioural factors as well as 
tum our characteristics and prognostic features. They found that the 
longest mean delay (6 months) occurred in patients whose MMs were on 
the back and in those with little or no previous knowledge of MM or its
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treatm ent. This group also dem onstrated a correlation betw een the 
Breslow thickness of superficial spreading MMs and length of delay. This 
relationship only held if tum ours diagnosed by coincidence during  
physical examinations for other purposes were excluded i.e. those w ith 
no delay at all. In contrast, however, a previous study of 245 MM patients 
had  how ever failed to show  any correlation  betw een  Breslow 
measurements and length of patient attributable delay. (119) This group 
found a mean delay of 8 m onths in their patients and no correlation 
between certain sites including the back and length of delay. They found 
that nodular MMs were associated with longer delays than the superficial 
spreading variety.
A more recent study from Australia (120) looked at delay data for 435 
patients with melanomas. No significant differences were found between 
time to diagnosis (delay) and Breslow thickness. The median duration to 
diagnosis from noting a change in the lesion was 5 months.
The results of the Scottish delay study suggested a general lack of 
knowledge of MM which might be at least partly corrected by a public 
education campaign on the subject. There was no indication from the 
results that any specific age group or sex of patient should be selectively 
targeted.
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CHAPTER THREE
3.1 Medical Education
3.1.1 General Introduction
Continuing medical education (CME) has been defined as postgraduate 
education designed to m ain tain  a consistently  h igh  s tandard  of 
preventative and curative care. (121) In general it excludes education 
taken to gain specific qualifications or diplomas.
This concept of CME assumes that anything other than perfect care 
reflects a lack of knowledge on the part of the doctor involved. It also 
assumes that the correction of this gap in knowledge will improve care. 
Neither assumption has been proven in the literature.
3.1.2 M ethods
A variety of educational methods may be used. The choice is dictated by a 
num ber of factors such as the num ber of learners, the subject m atter and 
the situation in which learning is taking place.
The most commonly used m ethod for large num bers of learners is the 
formal lecture. The lecturer can dissem inate know ledge from  m any 
sources and offer their own opinion on the subject. Visual aids e.g. 35mm 
slides and videotapes can be incorporated into the lecture to emphasise or 
more fully explain certain points. Some time is usually available for 
learners to ask questions.
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Smaller num bers of learners allow education to take place in the less 
form al tu torial setting. Students are encouraged to ask questions 
requiring more detailed answers and also to dem onstrate their ow n 
learning and experience of the subject. Tutorials allow the use of the 
same visual aids as the formal lecture.
Individual learners can use self-learning program m es to im prove their 
knowledge. The pace and tim ing of the learning can be com pletely 
dictated by the learner themself. Such learning program m es can use 
sophisticated education methods like computer and videotape or simple 
ones like tape slide presentations or written questions and answers.
3.1.3 Planning
The greater part of CME is arranged by professional organizations, 
hospitals and medical schools. Success in learning usually requires the 
presence of some form of stimulus. In some parts of the United States 
evidence of a certain am ount of participation in recognised CME 
programmes is essential for re-licensing purposes. Previously, in Britain, 
a financial incentive was offered to general practitioners for their 
attendance at designated courses and meetings. This practice has now  
been discontinued. For hospital doctors, attendance at recognised courses 
and meetings is allowed with pay and expenses granted by the employing 
Health Authority.
In designing a specific education program m e several factors have to be 
taken into account. These include the perceived goals of the program m e, 
the target audience, the type of information to be dissem inated and the 
most useful media for education.
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In medical education the so-called classical planning model is based on 
the belief that appropriate instruction will result in a change in doctor 
behaviour. Surprisingly little inform ation exists in the literature to 
confirm this point. Some education program m es have therefore as their 
perceived goal the correction of a recognised deficiency in health care. 
They aim to achieve this by im proving doctors knowledge and then 
altering their behaviour accordingly. In some program m es there may be 
more than one perceived goal or learning objective.
An appropriate target audience has to be selected for the programme. This 
is often dictated by specialist interest, geographical situation and resources 
of those organizing the programme. For program m es directed at doctors 
the choice is usually easily reached as to whether it should be aimed at 
general practitioners or at hospital doctors. Because the British health care 
system involves general practitioners as the prim ary health providers 
they are the ideal target for population based screening and for education 
programmes which include a public education component.
H ospital based program m es can use m ore sophisticated screening 
programmes on a selected population and may be more appropriate for 
some treatm ent- orientated program m es. D epending on the subject 
m atter the target audience can be widened to include other health care 
personnel e.g. hospital and community based nurses and health visitors.
3.1.4 Evaluation
If an educational program m e has well defined learning objectives, 
assessment of its success can be made by establishing whether these have 
been met. It is relatively straightforw ard to m easure the level of
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know ledge in the target audience before and after the education  
program m e. W hether an increase in inform ation results in altered 
behaviour and thus im proved patient care is m uch more difficult to 
measure. Only a few studies have tried to assess knowledge before and 
after education and very few have addressed its subsequent effects on 
patient care. Likewise the resulting behavioural and attitudinal change 
produced in the practitioner has not been studied.
A physician's performance in a defined clinical situation is dependant on 
his knowledge and also on the application of that knowledge. This latter 
factor is almost impossible to assess directly but will be a strong influence 
on more readily m easured patient outcome figures like m ortality data. 
Some aspects of physician behaviour can be m easured before and after 
education to give an indirect indication of its efficacy. These include 
referrals to specialists, biopsy or operation rates and requests for 
investigations like X-rays. A study of the effects of CME in Kansas (122) 
showed that there was no relationship betw een good perinatal and 
neonatal m ortality outcome figures and the am ount of obstetric CME 
undertaken by the physicians studied. Likewise in the same study there 
was no link betw een tonsillectomy rates and the am ount of CME in 
otolaryngology.
In most education programmes no attem pt at assessment of subsequent 
behaviour has been made. One study (123) show ed that surgeons' 
approaches to the ordering of blood for elective operations was altered 
after the issue of advisory guidelines by the transfusion staff. The w ritten 
advice was augmented by talks to groups of surgeons and discussion of 
individual transfusion requests by laboratory and clinical staff.
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Education evaluation is even more difficult w hen the target audience has 
been the general public. Some idea of knowledge can be obtained by 
questioning a randomly selected group of the target audience before and 
after education. This was done before the establishm ent of the Breast 
Cancer Screening Programme in Edinburgh. (124) These workers showed 
that the knowledge within the target population was increased after an 
education cam paign and that no sim ilar change occurred in a an 
"uneducated" control population. However, this study also showed that 
the increase in knowledge did not result in an increase in patients 
consulting their GPs about breast problems as had been anticipated.
Patient outcome figures can also be studied to give an indirect m ethod of 
the effect of education on the public. The Queensland Melanoma Project 
has reported an increasing proportion of thin, early MMs in recent years 
and consider that this is due to the tendency for their now well educated 
and MM- aware population to seek medical advice at an earlier stage than 
before.(103,104)
3.2 Cancer Education.
Public education in the field of cancer recognition and prevention is not a 
new concept. In general the most common types of cancer eg breast, lung 
and uterine cervix have been the subject of public campaigns. In several 
of the sunnier parts of the world the problem of skin cancer has also been 
addressed.
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3.2.1 Breast cancer
A major education campaign was carried out in Edinburgh to coincide 
w ith  the launch of a population- based breast cancer screening 
programme.(125) The authors tried to establish the level of knowledge of 
b reast cancer am ong the female p opu la tion  of E d inburgh  by a 
questionnaire, to then offer appropriate education and finally to re­
evaluate the level of knowledge on the subject. This latter value was then 
com pared w ith that of women in A berdeen w here no educational 
cam paign had taken place. As a result of earlier pilot studies the 
Edinburgh workers chose to use the small group discussion form at to 
spread the information.
The aims of the cam paign were to increase knowledge am ongst the 
susceptible population, to promote a positive attitude to the disease and 
to teach women to use self- examination to encourage diagnosis at an 
earlier stage. Evaluation of the campaign showed an increase in the level 
of knowledge in Edinburgh compared w ith Aberdeen. There was no 
behavioural change produced in that self-examination did not become 
more widely practiced. The authors acknowledged that increasing the 
level of knowledge m ight not necessarily result in earlier diagnosis. 
Other factors such as age and social class could affect the attitude to self- 
exam ination  or a ttendance at screening clinics desp ite  g rea ter 
knowledge.(126)
3.2.2 Other cancers
An evaluation of knowledge of testicular cancer was carried out by postal 
questionnaire in a group of young men. The recipients were selected to be
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of higher than average education. The authors found that knowledge was 
extremely poor and awareness of the value of self-examination alm ost 
non-existent.(127) These findings have led to a public education  
programme on testicular cancer.
3.2.3 Skin cancers
Most education campaigns have concentrated on m alignant m elanom a 
rather than squamous or basal cell carcinomas. Two different approaches 
have been used; (a) secondary prevention - early detection of MM at a 
thin, curable stage and (b) primary prevention - education on sensible sun 
exposure to reduce risk of developing MM.
The high incidence of MM has resulted in several major cam paigns in 
Australia most notably the Queensland Melanoma Project.(104) This has 
been running since 1963 utilising all available types of m edia. The 
cam paign was produced in response to the recognition of the high 
incidence of MM, at that time 16.5 per 100,000 population. The first 
publicity used a colour leaflet on diagnosing pigm ented lesions which 
was distributed to local doctors. The interest produced by this led to its 
being more widely distributed in Australia and also to other countries. 
The original leaflet was expanded to a more comprehensive one.
The interest generated by the leaflet was capitalised on by the use of 
multiple local and national talks and lectures. These were targeted both at 
the medical profession and at para-medical individuals like nurses and 
physiotherapists. This section of the educational venture was associated 
w ith an increase in the proportion of thin MMs being seen. This result 
led to similar campaigns in other parts of Australia.
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After the professional part of the program m e was established, a public 
education venture was introduced. The initial publicity used posters to 
dem onstrate the appearance of doubtful pigm ented lesions and then  
progressed to public meetings, press and radio publicity. The cam paign 
was conducted w ith very limited funding and thus television publicity 
could only be used when it was free e.g. when a doctor was asked to 
contribute to a planned programme. In the later years of the cam paign 
television advertising has been purchased to pass the campaign advice to 
maximum num bers of people.
Specific efforts have been made to educate schoolchildren and to identify 
high risk groups e.g. those w ith familial MM with or w ithout m ultiple 
atypical naevi.
As the campaign has run on it has been updated and altered to m aintain 
public interest and to include more preventative advice on sensible sun 
exposure. Those involved in the project noted that the public m em ory 
was fairly brief and that regular reminder campaigns were necessary to 
maintain the projects high public profile.
The main measure of success of the campaign has been the fact that in the 
face of a continuously rising MM incidence the Q ueensland MM 
mortality rate has been stable whereas that of other Australian states has 
risen. There has also been a continuing increase in the proportion of thin 
MMs seen.(103,104) Similar projects are also runn ing  in Victoria, 
Australia and in New Zealand.
In Hawaii, where a seven -fold increase in MM had been noted in recent 
years, an education campaign has been taking place. This has been aimed
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at four separate target groups: (i) physicians and surgeons, (ii) other 
health professionals like nurses and physiotherapists, (iii) non-health 
professionals like hairdressers and beauticians and (iv) the general public. 
The am ount and nature of the information was tailored to the target 
audience. Tape-slide preparations were used for the professional 
audiences and a comic book, television and radio announcements for the 
general public. (128) Subsequent evaluation  show ed tha t public 
knowledge was increased by these efforts by pre and post campaign testing 
of random ly sam pled members of the public. The most w idely cited 
method of learning was by television broadcasts.
An education program  was conducted in the low incidence area of 
Trento, Italy in 1977 and 1979.This consisted of the d istribution of 
pam phlets designed to encourage the early recognition of MM. The 
pam phlets were distributed to schools, pharm acies and hospitals.The 
advice included a 5 point checklist for lay use. The leaflets were discussed 
in local press and radio programmes. Patients were encouraged to attend 
the local derm atology departm ent for a free skin exam ination in the 
leaflet.
Their results were evaluated using aggregated annual data 1972-76 (pre­
publicity) and 1977-81 (post-publicity). The post-publicity years showed a 
fall in the proportion of thick (>3mm) lesions to 40.3% com pared to 
59.8%. Thin lesions (<1.5mm) had increased in proportion from 10.2% to 
32.6%.The authors attributed this change to their publicity.(129)
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3.3 Cancer Screening
Screening of the whole or "at-risk" members of the population for the 
more common varieties of cancer has taken place in various parts of the 
world. Most workers agree that screening is most effective in a well- 
informed population and thus most program m es follow a professional 
and public education campaign. Screening is best applied to diseases in 
which the following criteria can be met: the disease is common and has a 
significant m orbidity/m ortality, early treatm ent is helpful and a simple, 
patient-acceptable test is available.
3.3.1 Breast Cancer
More data is available for the assessment of screening for breast cancer 
than any other cancer. Most of the major screening efforts have been 
aimed at the 45-64 year old age group.
There are two main screening m ethods available - m am m ography + /-  
physical examination and education in breast self examination (BSE). A 
com parative trial of the m ethods was set up in 8 centres throughout 
B ritain . (130) In 2 centres annual exam ination  and  b ien n ia l 
m am m ography w as offered while 2 others offered education and 
encouragem ent in m onthly BSE. In the 4 other centres available for 
comparison no additional services were offered, breast cancers continuing 
to be m anaged in the established way(s). Evidence was emerging from 
other parts of the world that breast screening could have beneficial effects. 
The long running Health Insurance Policy study from New York showed 
a decrease in deaths from breast cancer in the screened com pared to 
unscreened women. Those cancers detected at screening were also more
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likely to be node negative than those presenting conventionally. (131) 
These findings have been confirmed by w orkers in other countries 
including Sweden.(132)
In the light of the above findings the Forrest report recom m ended 
screening all British wom en in the 50-64 age group by single view  
mammography. Repeat examinations were to occur every three years. 
Screening was to be available th roughou t the country at n inety  
designated centres some of which were to be mobile. They were to be 
staffed by appropriately trained nurses, radiographers and radiologists. 
Evaluation of the service including a cost per cancer diagnosed is 
underway.(133)
3.3.2 Cervical Cancer
Although Papanicolaou made a cytological diagnosis of cancer of the 
female genital tract by his "smear " technique in 1928 it was not until 1943 
that its use as a diagnostic test came to be recognized. By the 1960s the 
smear test was such an established technique that it was felt that it should 
be used as a screening test for all at-risk individuals. After pilot studies in 
Aberdeen (134) sm ear tests became available nationw ide. A lthough 
initially a hospital based service most tests are now carried out by general 
practitioners, by the family planning service or at "well women" clinics.
Evaluation of cervical screening program m es has show n a fall in 
incidence and m ortality of invasive disease coincident w ith large-scale 
screening exercises.(135) A Canadian study has further shown that the 
reduction in mortality correlated with the intensity of screening. (136) In 
addition, the trend to an increase in m ortality noted prior to the start of
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screening in 1964 appears to have been halted. (137) In Britain cervical 
screening is currently available to all wom en over thirty  every three 
years. There is no evidence that m ore frequent screening w ould  
significantly improve the pick-up rate of invasive tum ours (138)
3.3.3 Other Cancers
Several programmes are currently underway for screening for carcinomas 
in other sites including the lower bowel (139) and ovary. (140) These sites 
are much less accessible than cervix and breast and generally require a 
more invasive form of screening test. This has great implications for cost, 
personnel and facilities required and for patient acceptability of initial 
screening and follow-up tests.
3.3.4 M elanom a
Skin tum ours form an ideal target for a screening cam paign if clinical 
examination is taken to be both sensitive and specific. No specialized 
equipm ent is required and the screening test itself is quick and non- 
invasive.
Several screening ventures have taken place in the United States under 
the direction of the American Academy of Dermatology (AAD). In late 
March 1985 the first M elanom a/Skin Cancer Prevention W eek took 
place. The cam paign was nationw ide and utilized maximal local and 
national publicity to encourage the public to attend for a free and if 
possible, full skin examination. Examinations were m ade by volunteer 
dermatologists in hospital outpatient departm ents and in public places 
including  shopp ing  m alls. People w ere exam ined either by an
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appointm ent system  or on a "walk-in" basis according to local 
arrangements. In 1985, 22,000 people were screened and 42,000 in 1986. 
The screening involved only clinical assessm ent and patien ts w ith  
clinically suspicious lesions were advised to see a derm atologist for 
biopsy. In 1985 91 lesions which were clinically felt to be MMs were 
detected at screening and 262 in 1986. Many more individuals were found 
to have non MM skin cancer and precancerous conditions including 
actinic keratoses. All lesions were diagnosed clinically and subsequent 
histological confirmation was generally not available.(141)
The AAD publicity for the screening was not aimed at any special groups 
within the population. In general, more women than men attended (142) 
and 43% of those screened were aged less than 50 years. No data is 
available as yet from the AAD project to indicate whether screening has 
had any effect on melanoma m ortality and morbidity. Plans have been 
made, however, to continue with these annual campaigns. It has been 
argued that as melanoma is a relatively rare tum our screening should be 
d irected  only at h igh  risk ind iv idua ls ra ther th an  the  general 
population.(142).
'Similar screening has been done in Queensland (104) w hen people are 
(Offered free skin examinations on mobile units on beaches and in other 
public places. The rate of "pickup" of MM by this method is not available. 
The siting of the units on the beaches means that the appropriate high 
risk sunworshipping population is being targeted.
To date there has been no large scale MM screening program m e in 
B ritain and most effort has been directed at public and professional
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education. Given the rarity of the disease and the current doubt about the 
benefits of screening the general population there w ould be no strong 
argum ents for establishing such a programme here at present. From an 
educational point of view, there had been no large scale MM programme 
prior to 1985 though various interested individuals had been active at 
local levels.
Although screening may seem an attractive proposition for MM certain 
aspects of the process would require clarification. Firstly the exact nature 
of the skin examination e.g. total or limited. Secondly, the m ost useful 
screener needs to be identified e.g. specialist doctor, general practitioner or 
trained nurse. Finally evidence would be required to show that any effect 
on mortality would be sufficiently large to justify the capital and hum an 
costs of this type of exercise.
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CHAPTER FOUR
MATERIALS AND METHODS
The Glasgow Melanoma Campaign
4.1 Introduction
The professional part of the education program m e was designed for a 
target audience of all 650 general practitioners in the Greater Glasgow 
Health Board Area. It was decided to offer an amended version of the 
programme to other members of the primary health care team thereafter. 
These included hospital and community based nurses and district nurses.
The campaign had three aims; (a) cognitive - to increase knowledge, (b) 
attitudinal - to emphasise the value of treatment at an early stage and (c) 
behavioural - to encourage early referral of appropriately  screened 
patients. Much of the information for the campaign was best expressed 
visually rather than verbally. The prelim inary GP questionnaire had 
indicated that the preferred method of learning was a booklet, followed by 
talks, video-tapes and tape-slide presentations.
4.2 Materials
4.2.1 Booklets
The two m ost popular booklet subjects selected by the GP’s in the 
preliminary questionnaire were the recognition of the early MM and the 
clinical features of other benign pigm ented lesions. Two separate
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illustrated booklets were produced specifically for the campaign on these 
topics. Both contained many appropriate clinical photographs selected to 
help emphasis the points raised in the text. Included in the booklets were 
blank pages for note taking.
The first booklet dealt w ith the epidemiology, aetiology, clinical features 
and current m anagement of MM.(144) This comprehensive booklet gave 
a detailed description of the wide variety of clinical features observed in 
different types of melanoma with accompanying clinical photographs. A 
com panion booklet "An illustrated guide to benign pigm ented lesions" 
was also produced.(145) The clinical features of the more commonly 
encountered pigm ented lesions were described together w ith  their 
incidence, age of onset, m alignan t po ten tia l and  a p p ro p ria te  
management. Clinical photographs were used to illustrate the text.
4.2.2 Problem solving exercises
A book containing m anagem ent problem s arising in patien ts w ith 
pigm ented lesions was produced. This described the patient's history 
briefly and asked one or more key questions on m anagem ent on one 
page. The following page then offered the correct diagnosis and w idely 
accepted views on appropriate treatm ent. The latter were based on 
comments supplied by a wide range of experts in the melanoma field. 
These exercises could be used by the GPs as a means of self-assessment as 
well as a source of information.
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4.2.3 Clinical video
W ith the help of the Audio-Visual Department at Glasgow University a 
videotape on MM was produced for the campaign. The 17 m inute tape 
consisted of interviews conducted by Professor MacKie with patients who 
had primary or secondary MM. Patients in the former category were asked 
to describe the features that drew  their attention to their lesion, its 
duration  and their thoughts on the cause of any observed changes. 
T reated patients w ere asked about their prim ary  lesion and their 
subsequent therapies. Good, close-up views of prim ary lesions were 
obtained and their distinctive clinical features stressed. Information on 
MM sim ilar to that provided in the booklet was used in the video 
between interviews in the form of information cards and simultaneously 
in the script. A few patients w ith benign pigm ented lesions were also 
featured and the factors which could help distinguish MMs from such 
lesions were emphasised.
4.2.4 The 7 point checklist
The am ount of information in the campaign material was large and thus 
it w as felt that a sum m ary of the essential message was desirable. A 
checklist of factors which could be used by health professionals in the 
evaluation of pigm ented lesions was made. The 7 features which were 
m ost useful in distinguishing MMs from benign lesions were listed. This 
checklist was featured in both booklets and the videotape. The points are 
listed in Figure 2.
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4.2.5 Public Education Campaign
It was felt that public education would be most effective if carried out as a 
concentrated week of information using as many different types of media 
as possible. As people are generally more skin conscious at the time of 
their annual holiday the early summer was chosen as the optim um  time 
for this part of the campaign.
An illustrated poster and com panion leaflet were designed for the 
campaign, the costs of printing and distribution being initially met by the 
Greater Glasgow Health Board Health Education D epartm ent. These 
showed coloured pictures of typical melanomas and described the "at 
risk" individual. The 7 point checklist (Figure 2) was the most prom inent 
feature of both productions. Posters and leaflets were d istributed to 
general practitioners' surgeries, hospital outpatient departm ents, clinics 
and public libraries.
With the help of the Health Board Education Department a press release 
was prepared on the campaign for publication in the second week of June. 
It was initially given to all local and national Scottish new spapers only. 
The release drew  attention to the rising incidence of MM, its potential 
seriousness, the need for early diagnosis and to the use of the 7 point 
checklist for self examination. The public w ere encouraged to seek 
medical advice on any suspect lesions.
Air-tim e was requested on local and national radio and television 
program m es. In some instances MM patients were interview ed and 
described their experiences of diagnosis and treatment. On other occasions 
there was a interview  w ith a specialist (Professor R MacKie) who
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described the current increasing incidence, the need for early diagnosis 
and the value of self examination using the 7 point checklist. M edia 
publicity tended to be self perpetuating in that other new spapers and 
m agazines carried their version of the press release days or even weeks 
after the official campaign one. For this reason the publicity did not 
rem ain confined to a Melanoma week in June as in tended bu t was 
sustained throughout June and July. The time scale of the different 
components of the programme are shown in Figure 3.
Figure 2: 7 Point Checklist
1 Size > 1cm diameter, (blunt end of pencil)
2 Irregular outline.
3 Irregular pigm entation/ colour.
4 History of growth.
5 Itch.
6 Bleeding or discharge.
7 Inflam m ation.
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Figure 3: Education Cam paign Calendar
August - October 1984; GP q u estio n n a ire s  sen t ou t.
returned and evaluated.
December 84 - May 85; Professional education.
June/July 1985; In tensive pub lic ity  for public
education.
4.5 Evaluation
It was decided to attem pt to evaluate the public cam paign in several 
different ways. Direct questioning of the target audience was felt to be 
impractical due to the size of the audience and the lim ited funding 
available for the campaign. Thus assessment was m ade on the basis of 
change in patient behaviour and change in measurable patient outcome 
figures.
4.5.1 Patient Behaviour
The m ost predictable alteration in behaviour was thought to be an 
increase in people seeking advice on their pigm ented lesions. In the 
present health care system this would mean a rise in consultations w ith 
GPs, a factor which would be extremely difficult to m easure accurately 
due to the large num ber of doctors involved. Instead it was decided to 
m easure the num ber of pigm ented lesions referred to all Glasgow 
dermatology departments which, in the absence of a major change in GPs
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referral habits w ould m irror alterations in the GP consultations. The 
num ber of pigm ented lesion referrals to the five m ain Dermatology 
departm ents in the two months of maximal public education (June and 
July 1985) w ere counted using the disease index system  of each 
departm ent. The figures were compared w ith those of the same months 
in 1984. As the vast majority of pigmented lesions in Glasgow are referred 
to the designated Pigmented Lesion Clinic (PLC) at the Western Infirmary 
it w as decided to count only the referrals to this clinic over a longer 
period of time to allow for seasonal variations in num bers. Thus the 
referrals to the PLC were monitored for the three year period starting 
December 1983. This gave the numbers referred during the professional 
and the public campaign compared to the years preceding and following 
them .
4.5.2 Pigmented Lesion Clinic
At the Western Infirmary there was a designated PLC already established. 
This allowed rapid referral of any suspect pigm ented lesions usually 
w ithin 2 weeks. The clinic initially was conducted by two medical staff 
though as the campaign progressed additional personnel were required. 
Lesions suspected of being MMs at the clinic were removed at the time if 
feasible or w ithin a few days if more complex surgery was required. A 
clinical photographer was present throughout each clinic.
4.5.3 Effects of Publicity
A questionnaire (see Appendix) concerning the possible influence of 
publicity on referral was administered to 50 consecutive patients seen at 
the designated PLC at the Western Infirmary in the summer of 1985. The
63
same questionnaire was sent to 50 consecutive patients attending non- 
PLC dermatology clinics in Glasgow and 29 in Dundee during the same 
period. These individuals were identified from diagnostic indices as 
having been referred with a pigmented lesion.
A designated PLC was set up in 1985 in the Royal Infirmary in Edinburgh. 
Publicity related questionnaires were also completed by 118 patients 
attending there.
Questionnaires were intended to be anonymous though the city of origin 
was identifiable. Patients were asked their age, sex and whether they had 
been aware of the current Glasgow Melanoma campaign. Those who had 
heard of it were offered a choice of the names of national and local 
newspapers, television and radio program m es which had featured the 
cam paign and asked to select the one(s) they had encountered. Other 
proffered information sources included leaflets/posters and "other". The 
latter option gave space for comment. Those who had not heard of the 
campaign were offered some possible reasons for having consulted their 
GP about their pigmented lesion. These included advice from friends and 
relatives, change in or development of sym ptoms in their pigm ented 
lesion and existing awareness of the potential seriousness of pigm ented 
lesions.
4.5.4 Surgeons’ and Pathologists' Workloads
The above referral data gives some indication of the change in referrals to 
dermatologists throughout the city. In order to assess changes in referrals 
to other outpatient clinics eg plastic or general surgery and to monitor any 
change in histopathologists' workloads the numbers of pigmented lesions
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excised throughout Glasgow during the designated three year period were 
m easured.
This was done by counting the num bers of histologically diagnosed 
lesions of the types which are most commonly confused with MMs on 
clinical grounds. These are melanocytic naevi, seborrhoeic keratoses, 
dermatofibromas, benign vascular lesions and basal cell carcinomas. At 
the time that this data was collected none of the contributing pathology 
laboratories had computerised records. Thus all the data was m anually 
extracted from pathology request forms in all pathology departm ents in 
the city. In the W estern Infirmary the m ajority of skin specimens are 
processed in the dermatopathology laboratory and a smaller num ber in 
the m ain pathology department. Data was collected from both sources. 
Four of the laboratories involved classified specim ens using coding 
systems which helped in identifying the relevant request forms bu t in 
two sites these had to be manually extracted from a general skin file. Note 
was taken of those instances where the clinical diagnosis was thought to 
be melanoma.
Material was received in all five hospitals from both dermatologists and 
general surgeons. The laboratories at the Western and Royal Infirmaries 
also processed specimens from the Regional Plastic Surgery U nit at 
Canniesburn Hospital in Glasgow.
4.5.5 Patient Outcome
The most im portant initial measure of the success of the campaign was 
the num bers and types of m elanom a seen and in particu lar the 
proportion of thin, early tumours. With the co-operation of the Scottish
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Melanoma Group data was obtained of the numbers, histological types 
and Breslow thicknesses of all MMs removed in the West of Scotland for 
the year of the campaign and the years preceding and following it. The 
final m easure of the effect of the campaign will be the m ortality data 
obtained in the future.
4.5.6 Finance
Funding for the campaign was obtained from the Camilla Samuel Fund 
which paid for a part-time salary for a registrar in 1985 and 1986. The cost 
of the first p rin ting  of the two booklets w as m et initially by the 
Departm ent of Dermatology of the University of Glasgow and thereafter 
by a pharmaceutical company. The costs of production and distribution of 
the posters and leaflets for public education were met by the Health 
Education Group of the Greater Glasgow Health Board. Publicity in the 
press, television and radio was provided free.
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CHAPTER FIVE
RESULTS
5.1 Uptake of Materials
5.1.1 General practitioner questionnaire
(The pre campaign general practitioner questionnaire is in Appendix A.)
A total of one hundred questionnaires were distributed to a random ly 
selected group of Glasgow's 650 general practitioners. Questionnaires 
were accompanied by a reply paid post card by which further information 
could be requested. Sixty nine completed questionnaires were received 
(69%) and all were evaluable.
Replies to individual questions were as follows.
(i) The recognition of early m alignant melanoma is a subject 
about which in general GPs are not confident because of its 
relative rarity.
Options: Agree/Disagree.
61 of 69 (88%) of GPs agreed that there was a lack of confidence 
in the early recognition of melanoma.
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(ii) If the following forms of m aterial were available to help 
compensate for this lack of personal experience, which do you 
consider would be most useful?
Illustrated booklet 46/69 (67%)
Videotape 37/69 (54%)
Local meetings 35/69 (51%)
Tape-slide 16/69 (23%)
Car tape 9/69(13%)
Phone 0/69 (0%)
(iii) Which of the above would you anticipate being most useful 
to the majority of GPs?
Booklet 37/69 (54%)
Meetings 20/69 (29%)
Video tape 8/69 (12%)
Car tape 4/69 (6%)
Tape-slide 2/69 (3%)
Phone 0/69 (0%)
(iv) Do you consider that the needs of trainee GPs, as far as this 
topic is concerned, are different from those of established 
GPs?
Options: Yes/No. 58/69 (84%) - Yes
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(v) Which of the following possible topics for educational leaflets 
would you consider most GPs would find helpful in this area 
of knowledge?
Options: Definitely useful and interesting/ Probably useful/ Not
of great interest.
Table 5.1: M M  Topics- Value to GPs.
Topic
Definite
Perceived value 
Probable N ot
MM-Early Recognition 92 7 1
Norm al moles 63 26 9
MM-Pathology 12 41 47
MM-Surgery 13 56 28
Disseminated MM 23 44 23
M anagem ent
MM & Pregnancy 47 44 7
MM-Epidemiology 13 43 38
Dangers of excess sun 53 36 9
(vi) Do you have any personal anecdotal case history of practical 
experience in this field which might be used (anonymously or 
not) for the educational exercise?
Options: Yes/No.
Yes: 13/69 (19%)
*Figures refer  to number o f  GPs assess ing  
usefulness o f  each topic.
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(vii) W ould you welcome more information on the appropriate 
procedures to initiate if a patient walks into your surgery with 
a suspect melanoma?
Options: Yes/No.
Yes: 51/69 (74%)
(viii) W ould you welcome inform ation on current appropriate  
therapeutic procedures for melanom a in order to inform 
patients of the likely course of events?
Options: Yes/No
62/69 (90%)
(ix) W ould you welcome educational material or an educational 
campaign aimed at your patients to encourage them to attend 
for exam ination  of "odd moles" and  possib le  early  
m elanom a?
Options: Yes /N o /  Only after the GP program m e has been
distributed.
Yes -25/69 (36%)
Yes but preceded by GP education - 36/69 (52%)
No - 8/69 (12%)
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5.1.1.1 Requests fo r  fu r th er  information
A  total of ninety one cards requesting further information were received. 
Of these, there were ninety one requests for the booklet on benign 
pigmented naevi, sixty three for the problem solving exercises and seven 
for the videotape. A further seven practices requested a showing of the 
videotape at a later date.
5.1.2 Professional Update
5.1.2.1 Local M eetings
D uring the six m onth professional update six meetings were held in the 
W est of Scotland and attended by about 350 general practitioners. These 
sessions usually consisted of a talk on melanom a, a view ing of the 
videotape and an opportunity to ask questions on the topic. Copies of the 
melanom a, benign naevi and problem solving exercises booklets were 
available at all the meetings.
5.1.2.2 N ursing  S ta ff Update
Separate meetings were held during the professional update period for 
hospital and community nurses in the West of Scotland. Meetings were 
held in six different venues and audiences included student and qualified 
hospital nurses, district nurses and health visitors. At these sessions the 
clinical video was shown and a question and answer period followed. All 
sessions were attended by at least one of the contributing dermatologists. 
Copies of the videotape were made available to senior nursing teaching 
staff who showed the video on further occasions in individual hospitals
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to nurses unable to attend the main meetings. Copies of the campaign 
booklets, posters and leaflets were also available at the nurses meetings.
5.1.3 Public Education
5.1.3.1 Press release
A press release was produced w ith the advice and co-operation of the 
Health Education Department of Greater Glasgow Health Board. Publicity 
was requested for the first week in June 1985. The following newspapers 
carried the release: the Times, Observer, Guardian, Scotsman, Glasgow 
Herald, Daily Record, Sunday Mail, Coventry Evening News and the 
N ursing Times.
5.1.3.2 Television and radio publicity
The education  cam paign received publicity  du ring  the follow ing 
television programmes: BBC National News, BBC Breakfast Time, BBC 
Reporting Scotland and Body line. Radio publicity was through the 
following: BBC Radio 4-"Today", Woman's Hour, Tell Me More (science 
program m e). Radio Clyde (local West of Scotland), Radio Solent and 
Radio Sheffield.
5.1.3.3 Requests fo r  fu r th e r  information
Following the major publicity there were m any requests for further 
information from the lay public, professional organizations and doctors. 
Fifty three letters were received from the general public from all parts of 
Britain. All the letters were answered and copies of the campaign leaflet 
enclosed. Further inform ation was sent on request to the following
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associations: British Association of Cancer United Patients, Association of 
Sun Tanning Operators, Institute of Electrolysis and the Central Council 
for British Naturism.
5.2 M onitoring
5.2.1 Pigmented Lesion Referral Patterns
The num bers of pigm ented lesions seen at the five major teaching 
hospitals in Glasgow during the time of maximum publicity (June and 
July 1985) were obtained from the diagnostic index of each of their 
Dermatology departments. The num bers were compared w ith those of 
June and July 1984. For this assessment, "pigmented lesion" was defined 
as melanocytic naevus, dermatofibroma, angioma, seborrhoeic w art and 
basal cell carcinoma. The figures are given in Table 5:2.
Table 5.2: Non-M elanoma Pigmented Lesions 
Glasgow - Non-PLC
Hospital 1984 1985 % change
Royal Infirmary 58 63 +8.6
Victoria Infirmary 40 56 +40
Stobhill 36 51 +41
Southern General 24 48 +100
Others* 12 25 +108
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Others* = smaller hospitals in West of Scotland outside Glasgow itself.
A proforma was completed for all new patients attending the PLC at the 
W estern Infirmary. Data was collected for the twelve months preceding 
the professional education (December '83 - November '84), the campaign 
year (December '84 - Novem ber '85) and the post cam paign year 
(December '85 - November '86). Details of the patients age, sex, referring 
GP, site of lesion, clinical and histological diagnoses and treatm ent if any 
were noted.
These figures are shown in Table 5:3 for each of the years studied.
Table 5.3: PLC Clinic Data
Numbers of Patients Seen, Age and Sex Distribution.
1984 1985 1986
N um bers 155 573 759
Female 112 392 549
Male 43 181 210
F:M 2.6:1 2.2:1 2.6:1
F: Ages
Range (Years) 0.1-87 1-90 3-94
M edian 36.5 40.7 41.64
M: Ages
Range (Years) 5-83 1-83 4-79
M edian 37 45 36
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Table 5.4: PLC Data.
Proportion of New Patients Biopsied
Year 1984 1985 1986
Num ber of patients seen 155 573 759
Number of biopsies taken 103 285 246
Percentage of PLC patients 
biopsied 66.7 49.7 32.4
Table 5.5: PLC Data: Clinical Diagnoses.
Num ber of each type of lesion & percentage biopsied
Type of lesion 1984 1985 1986
BCC 7 80% 16 93% 15 93%
Seborrhoeic wart 41 6g.g% 171 32.7% 188 11.7%
Benign naevus common 37 67.6% 158 44% 253 34%
Benign naevus other 8 31. S% 11 45% 12 33.3%
Congenital naevus 6 50% 50 58% 44 6.8%
Atypical naevus 8 75% 24 37.5% 40 30%
Angiom as 13 17 6L1% 19 LtTl^ /o
Dermatofibromas 2 100% 17 59.%% 20 65%
M elanom as 23 100% 35 100% 42 100%
Lentigo maligna 2 100% 11 100% 17 94%
Others 8 63 109
Total 155 573 759
Comment; benign naevus-other = blue. Spitz, Becker's, naevus spilus and spindle cell 
naevus of Reed.
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Table 5.6: PLC Data: Clinical Diagnoses
Types of pigmented lesions as percentage of total num ber of lesions seen.
Type 1984 1985 1986
BCC 7 4.5% 16 2. % 15 2%
Seborrhoeic Wart 41 26.5% 171 29.8% 188 24.8%
Benign naevus common 37 23.9% 158 27.6% 253 33.35%
Benign naevus other 8 S.Z% 11 1.9% 12 1.6%
Congenital naevus 6 3.9% 50 8.7% 44 5.8%
Atypical naevus 8 SZ% 24 4.2% 40 5.3%
Angiom as 13 8.4% 17 Z % 19 2.S%
Dermatofibrom as 2 1.3% 17 2>% 20 2.6%
M elanom as 23 35 6% 42
Lentigo maligna 2 1.3% 11 1.9% 17 2.2%
Others 8 5.2% 63 11.0% 109 14.4%
Total 155 573 759
The campaign year caused a marked rise in referrals of new patients to 
the pigmented lesion clinic. Attendances increased by 273% in 1985 and by 
a further 32.5% in 1986. In all three years more female than male patients 
were seen and the female to male ratio showed no significant change 
over the three study years.(2.6:l, 2.2:1, 2.6:1 respectively).
The num bers of patients seen with various types of clinically diagnosed 
pigmented lesion are seen in Table 5:5. This also indicates the proportions
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of each type submitted for histological evaluation. During 1985 and 86 the 
p roportion  of some of the five designated types of lesion sent for 
histology fell markedly. The percentage of seborrhoeic warts biopsied fell 
by almost a half in 1985 and by a further two thirds in 1986. The figures 
for benign naevi biopsied dropped by a third in 1985 and by a quarter in 
1986. Overall the total percentage of PLC patients biopsied varied greatly 
in the three study years. In 1984, 66.6% of patients had a biopsy performed 
and the rates for 1985 and 1986 were 49.7% and 32.4% respectively.
In table 5:6 the individual clinical diagnoses are displayed as a percentage 
of the total num ber of lesions seen at the clinic for each year. In 1985 
despite the marked increase in total numbers of patients seen there was 
no evidence of this being due to an increase in one specific type of lesion. 
The significant changes in the 1985 figures were falls in the proportions of 
vascular lesions, BCCs, m elanom as and "other" benign naevi. The 
categories showing a significant increase after 1984 were congenital naevi 
increasing from 3.9% to 8.7% and the "other" group which rose from 5% 
to 11% in 1985. The percentages of the two m ost common lesions, 
seborrhoeic w arts and common benign naevi bo th  show ed sm all 
increases only.
In 1986 there was a further significant fall in the percentage of BCCs and 
of congenital naevi. The proportions of vascular lesions, melanomas and 
"other" benign naevi showed no further significant change. There was a 
further small increase in the proportion of seborrhoeic warts and "other" 
lesions seen.
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Thus it appeared that the m arked increase in attendees at the clinic 
caused a relative dilution of the m alignant skin tum ours including 
m elanom a. The rise in congenital lesions seen m ay be due to their 
tendency to have atypical clinical features which would score some points 
on the 7 point check-list. The percentages of the two types of lesion which 
constitute the major workload of the clinic ie common benign naevi and 
seborrhoeic warts both increased in 1985.
5.2.2 Effects of Publicity
A questionnaire concerning the possible influence of publicity on referral 
was given to 50 consecutive patients seen at the designated PLC at the 
W estern Infirmary, to 50 patients attending non-PLC dermatology clinics 
in Glasgow and to 29 patients in Dundee during the summer of 1985. 
These latter two groups of patients were identified from diagnostic 
indexes as having  been referred w ith  a p igm ented  lesion. The 
questionnaires were also completed by 118 consecutive patients at the 
pigmented lesion clinic in the Royal Infirmary, Edinburgh.
The results of the questionnaires are given in Tables 5:7 and 5:8. The full 
questionnaire is in the Appendix.
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Table 5.7: Publicity Questionnaires: Age & Sex. 
No. o f patients aware o f Glasgow publicity
Replies Y
Glasgow
N T Y
Edinburgh
N T Y
Dundee
N T
Age (years) 
0-20 5 8 13 6 17 23 1 1 2
20-40 13 10 23 10 25 35 2 3 5
40-60 24 4 28 16 23 39 1 2 3
> 60 11 10 21 6 15 21 2 8 10
Total 53 32 85 38 80 118 6 14 20
Sex: F 41 26 67 32 56 88 4 11 15
M 12 6 18 6 24 30 2 3 5
Femalermale 3.7:1 2.9:1 3:1
Y=yes N=no T=total
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Table 5.8: Publicity Questionnaires. 
M ost useful m edium
M edium Glasgow Edinburgh Dundee
TV:National 27 16 2
50.9% 42%
TViLocal 26 16 1
49.1% 42%
Radio:National 2 4 0
3.8% 10.5 0
Radio:Local 11 4 0
20.8% 10.5%
Press: National 5 8 0
9.4% 21.1%
Press:Local 26 14 2
49.1% 36.8%
Posters/leaflets 8 3 1
15.1% 7.9%
Total 53 38 6
Numbers refer to numbers of patients quoting each type of medium as their information 
source. Percentages are of total patients replying in each city.
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A significantly greater proportion of patients attending the derm atology 
clinics in Glasgow had been aware of the campaign publicity compared to 
those in E dinburgh and D undee (62% com pared to 32 and 30% 
respectively). The num bers of questionnaires from Dundee was small 
and these have not been further broken down to look at effects of age 
a n d /o r  sex. Perhaps people pay more attention to media items related to 
their home city and are more likely to remember them. In addition the 
extra publicity in Glasgow including posters, leaflets, local radio and local 
press may help explain the disparity.
The overall effect of the publicity may well have been under estimated as 
a large num ber of those who were personally unaware of the publicity 
stated that they had been encouraged by friends and relatives to seek 
medical advice. It is possible that theses individuals offered the advice 
because of the publicity. It is of note that there was an increase in referrals 
of pigm ented lesions in both Edinburgh and Dundee at the time of the 
cam paign (personal communications) suggesting that these areas were 
affected by overspill publicity.
Looking at the results from Glasgow and E dinburgh only, some 
differences in the groups questioned are seen. The percentage of patients 
under 40 was higher in Edinburgh (58/118, 49.2%) than in Glasgow (36/85, 
42.4%). The female : male ratio in Glasgow was higher than that in 
Edinburgh, 3.7:1 and 2.9:1 respectively. As the patients who completed the 
questionnaire were not selected in any way these differences presumably 
reflect a differing section of the population attending the PLC in the two 
cities.
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In the Glasgow group the percentage of men and women who had heard 
of the publicity  w as virtually  identical (12/18,67% for m en and 
41/67,61.2% for women). Among Edinburgh patients, however, a higher 
percentage, 36.4% (32/88)of women were aware of the publicity compared 
to 20% (6/30) of men. The most widely cited m ethod of learning of the 
campaign was by television both local and national. Sixty-two percent of 
respondees in Glasgow, 27.6% in Edinburgh and 50% in Dundee had  been 
alerted in this way. A short item featured on the BBC national evening 
news proved to be the single most quoted method in all three centres.
5.2.3 Histological Data.
All lesions excised and histologically diagnosed as one of the five 
categories of p igm ented lesion i.e. m elanocytic naevi, basal cell 
carcinomas, seborrhoeic warts, angiomas and derm atofibrom ata were 
counted for the pre- campaign, campaign and post-campaign years.
This data was collected from request forms filed in six histopathology 
departm ents in Glasgow. These were sited at the W estern, Royal and 
Victoria Infirmaries and Stobhill and Southern General Hospitals. The 
W estern Infirmary site receives some skin pathology specimens into the 
main pathology laboratory but the great majority of material is sent to the 
derm atopathology department there. In four of the departm ents reports 
w ere filed using a coding system which allowed for selection of the 
different pigm ented lesion categories. In the other two the required 
categories had to be manually extracted from a more general "skin lesion" 
file for counting.
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M aterial was received in all five hospitals from general surgeons and 
derm atologists. The laboratories at the W estern and Royal Infirmaries 
processed all the specimens from the West of Scotland Regional Plastic 
Surgery Unit at Canniesburn H ospital in Glasgow. The results are 
presented in Tables 5:9-5:14 for each hospital separately and summarised 
in Table 5:15.
Table 5.9: Pigmented Lesions - Histological Data.
Royal Infirmary 1984 1985 1986
Melanocytic Naevi 436 455 463
BCC 790 700 708
Seborrhoeic warts 190 302 317
A ngiom as 71 53 49
Dermatofibrom as 46 52 41
Total 1533 1562 1578
% change - +1.9 +1
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Table 5.10: Histological Data
Southern General Hospital 1984 1985 1986
Melanocytic Naevi 50 108 98
BCC 55 69 67
Seborrhoeic warts 60 88 115
Angiom as 8 22 18
Dermatofibromas 14 18 38
Total 187 305 336
% change - +63 +10
Table 5.11: Histological Data
Victoria Infirm ary 1984 1985 1986
Melanocytic Naevi 278 256 303
BCC 173 149 136
Seborrhoeic W arts 99 136 92
Angiom as 51 50 36
Dermatofibromas 42 62 65
Total 643 653 632
% change - +1.5 -3.2
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Table 5.12: Histological Data
Stobhill Hospital 1984 1985 1986
Melanocytic Naevi 88 127 122
BCC 47 55 65
Seborrhoeic Warts 45 69 58
Angiom as 20 21 19
Dermatofibrom as 7 28 35
Total 207 300 299
% change - +44.9 -.3
Table 5.13: Histological Data
W estern Infirmary-General Laboratory
1984 1985 1986
Melanocytic Naevi 49 41 44
BCC 14 17 16
Seborrhoeic W arts 30 31 26
Angiom as 14 7 19
Dermatofibromas 22 20 21
Total 129 116 126
% change - -10 +8.6
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Table 5.14: Histological Data
W estern Infirmary- Dermatopathology Laboratory
1984 1985 1986
Melanocytic Naevi 219 354 362
BCC 180 202 237
Seborrhoeic W arts 160 267 192
A ngiom as 45 26 40
Dermatofibromas 37 24 40
Total 641 873 871
% change - +36.2 -0.2
Table 5.15: Histological Evaluation.
All Glasgow Laboratories 1984 1985 1986
Melanocytic Naevi 1128 1341 1392
BCC 1273 1192 1229
Seborrhoeic W arts 573 893 800
Angiom as 211 173 156
Dermatofibromas 171 204 240
Total no. "lesions" 3356 3803 3817
% change - +13 +0.4
Total - all specimens 50947 51123 52055
"lesions" = basal cell carcinomas, seborrhoeic warts, naevi, angiomas and 
dermatofibromas.
Specimens = total number of all categories of material received by pathology department.
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Over the three year study period the variation in num bers of pigmented 
lesions excised and submitted for histology was fairly small in Glasgow as 
a whole. In 1985 this increase was 13% of the 1984 value and there was a 
further rise of only 0.4% between 1985 and '86. D uring 1985 the m ain 
change was an increase in excised seborrhoeic w arts (+55.9%) w ith  
sm aller rises in naevi (+18.9%) and derm atofibrom ata (+19.3%). There 
w ere falls in the num bers of BCCs and angiom as.(-6.4% and -18% 
respectively)
Figures from the Royal Infirmary (table 5:9), Victoria Infirmary (table 5:11) 
and general pathology departm ent of the W estern Infirmary (table 5:13) 
show  virtually  no change over the three years. In the other three 
departm ents (tables 5:10, 5:12, 5:14) there were overall rises in total 
num bers w ith  changes of + 63, +45 and +36% noted in 1985. The 
diagnostic categories showing the largest rises were naevi and seborrhoeic 
warts. The num bers of these types and indeed of all excised lesions were 
virtually unchanged in 1986.
During the study years there were small non-significant changes in the 
total numbers of all types of surgical specimens processed throughout the 
city. These were a rise of 0.3% in 1985 and a further 1.8% increase in 1986. 
This implies that the observed 13% increase in skin specimens seen in 
1985 was a reflection of a specific increase in excisions of skin lesions.
The changes in the numbers of excised lesions are similar to those noted 
for change in referral patterns. The Royal Infirm ary had the smallest 
increase in referred lesions and the least rise of excised ones whilst the 
Southern General and W estern Infirmaries saw the largest increases in
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both. The increase at the Western is attributable to the PLC but their is no 
obvious local explanation for the figures for the Southern General.
5.2.4 Melanoma Data
The num bers of melanomas registered in the West of Scotland during 
the three study years and till 1990 are shown in table 5:17 and those for 
preceding years in table 5:18. Figures were obtained from the Scottish 
Melanoma Group data and refer to calendar years. Numbers of cases are 
sub-divided into males and females and also into the three Breslow 
thickness categories previously described. In table 5:17 the melanomas are 
categorised according to histogenetic types,
Table 5.16: W est o f  Scotland M elanom a Data
Annual numbers of melanomas categorized by sex with number and percentages of Breslow
thickness bands.
Year 0-1.49mm 1.5-3.49mm >3.5m Other Total
1984 M 18 (27.2) 15 (22.7) 27 (40.9) 6 (9.1) 66 (100)
F 60 0W.6) 31 (25.6) 23 (19.0) 7 (5.8) 121 (100)
T 78 (41.7) 46 (24.5) 50 (26.7) 13 (6.9) 187 (100)
1985 M 30 (43.5) 14 (20.3) 22 (31.9) 3 (4.3) 69 (100)
F 75 (53.6) 35 (25.0) 25 (17.9) 5 (3.6) 140 (100)
T 105 (50.2) 49 (23.4) 47 (22.4) 8 (3.8) 209 (100)
1986 M 32 (43.8) 20 (27.4) 18 (24.6) 3 (4.1) 73 (100)
F 80 (48.2) 40 (24.1) 39 (23.5) 7 (4.2) 166 (100)
T 112 0W9) 60 (25.1) 57 (23.8) 10 (4.2) 239 (100)
1987 M 29 (37.2) 13 (16.7) 29 (37.2) 7 (9.0) 78 (100)
F 88 (62.4) 22 (15.6) 25 (17.7) 6 (4.2) 141 (100)
T 117 (53.4) 35 (16.0) 54 (24.7) 13 (5.9) 219 (100)
1988 M 46 (54.8) 19 (22.6) 15 (17.9) 4 (4.8) 84 (100)
F 82 (55.8) 33 (22.4) 30 (20.4) 2 (1.4) 147 (100)
T 128 (55.4) 52 (22.5) 45 (19.5) 6 (2.6) 231 (100)
1989 M 62 (57.4) 24 (22.2) 19 (17.6) 3 (2.8) 108 (100)
F 69 (54.3) 30 (23.6) 24 (18.9) 4 (3.1) 127 (100)
T 131 (55.7) 54 (23.0) 43 (18.3) 7 (3.0) 235 (100)
1990 M 45 (46.4) 17 (17.5) 28 (28.9) 7 (7.2) 97 (100)
F 104 (63.4) 35 (21.3) 18 (10.9) 7 (4.3) 164 (100)
T 149 (57.1) 52 (19.9) 46 (17.6) 14 (5.4) 261 (100)
M = male F = female T = total
* Other = lesions in which Breslow thickness could not be estimated.
Numbers in parenthesis refer to proportions of patients in each thickness category for 
males, females and all patients.
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Table 5.17: West o f Scotland Melanoma Data
Annual number of melanomas categorized by sex and numbers and proportions of
histogenetic types.
Year SSM LMM NM ALM Other Total
1984 M 29 (43.9) 6 (9.1) 17 (25.8) 3 (4.5) 11 (16.7) 66 (100)
F 79 (65.3) 13 (10.7) 23 (19.0) 6 (4.9) 7 (5.8) 121 (100)
T 108 (57.8) 19 (10.2) 40 (21.4) 9 (4.8) 18 (9.6) 187 (100)
1985 M 27 (47.4) 9 (15.8) 16 (28.1) 2 (3.5) 3 (5.3) 57 (100)
F 68 (55.7) 13 (10.7) 25 (20.5) 8 (6.6) 8 (6.6) 122 (100)
T 95 (53.1) 22 (12.3) 41 (23.0) 10 (& 0 11 (6.1) 179 (100)
1986 M 39 (57.3) 7 (10.3) 15 (22.1) 4 (5.9) 3 (4.4) 68 (100)
F 86 (55.1) 25 (16.0) 30 (19.2) 4 2^0 11 (7.1) 156 (100)
T 125 (55.8) 32 (14.3) 45 (20.1) 8 (3.6) 14 (6.3) 224 (100)
1987 M 36 (43.6) 12 (15.4) 22 (28.2) 3 (3.8) 7 (9.0) 9 0 (100)
F 84 (59.2) 18 (12.7) 25 (17.6) 4 (2.8) 11 (7.7) W (100)
T 12-0 (53.6) 30 (13.6) 47 (21.4) 7 (3.2) 18 (8.2) 27 Z. (100)
1988 M 54 (62.0) 7 (3.0) 15 (17.2) 1 (1.1) 10 (11.5) 87 (100)
F 90 (61.0) 20 (13.5) 33 (22.3) 4 (2.7) 1 (0.7) 148 (100)
T 144 (61.3) .. 27 (11.5) 48 (20.4) 5 (2.1) 11 (4.7) 235 (100)
1989 M 65 (60.2) 9 (8.3) 26 (24.1) 4 (3.7) 4 (3.7) 108 (100)
F 83 (65.4) 11 (8.7) 24 (18.9) 5 (3.9) 4 (3.1) 127 (100)
T 148 (63.0) 2.0 (s.f) 50 (21.3) 9 (3.8) 8 (3.4) 235 (100)
1990 M 55 (55.6) 6 (6.1) 21 (21.2) 6 (6.1) 11 (11.1) 99 (100)
F 111 (63.1) 22 (12.5) 23 (13.1) 8 (4.5) 12 (6.8) 176 (100)
T 166 (60.4) 28 (10.2) 44 (16.0) 14 (5.1) 23 (8.4) 275 (100)
M = male F = female T = total
* Other = lesions of other melanoma types or which are unclassified.
Numbers in parenthesis refer to proportions of total numbers with each type of melanoma 
for males, females and all patients.
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Table 5.18: West of Scotland Melanoma Data 1S79-198S
Total number of melanomas categorized by sex and histogenetic type
Year SSM IMM NM ALM Other Total
1979 M 16 (41.0) 3 (7.7) 10 (25.6) 5 (12.8) 5 (12.8) 39
F 57 (58.2) 13 (13.2) 14 (14.3) 7 (7.1) 7 (7.1) 98
T 73 (53.3) 16 (11.7) 24 (17.5) 12 (8.8) 12 (8.8) 137
1980 M 27 (54.0) 3 (6.0) 9 (18.0) 5 (10.0) 6 (12.0) 50
F 50 (49.5) 16 (15.8) 18 (17.8) 7 (6.9) 10 (9.9) 101
T 77 (51 ) 19 (12.6) 27 (17.9) 12 (7.9) 16 (10.6) 15/
1981 M 22 (47.8) 2 (4.3) 11 (23.9) 7 15.2) 4 (8.7) 46
F 44 (47-3) 14 (15.1) 20 (21.5) 4 (4.3) 11 11.8) 93
T 66 (47.5) 16 (11.5) 31 (22.3) 11 (7.9) 15 (10.8) 139
1982 M 21 (42.9) 8 (16.3) 8 (16.3) 8 (16.3) 4 (8.2) 49
F 37 (42.0) 12 13.6) 22 (25.0) 9 (10.2) 8 (9.1) 88
T 58 (42.3) 20 (14.6) 30 (21.9) 17 (12.4) 12 (8.8) 137
1983 M 22 (40.0) 7 (12.7) 18 (32.7) 4 (7.3) 4 (7.3) 55
F 65 (57.5) 9 (7.9) 25 (22.1) 5 (4.4) 9 (7.9) 113
T 87 (51.8) 16 (9.5) 43 (25.6) 9 (5.4) 13 (7.7) 168
M = male F *= female T = total
Numbers in parenthesis refer to percentages of each type of melanoma for males, females 
and all patients per annum.
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Table 5.19: W est o f  Scotland M elanom a Data
5 year disease free survival figures for MM patients presenting 1979-1985 
categorized by sex and Breslow thickness band
Breslow Measurement
Not
Year 0-1.49 1.5-3.49 >3.5 available Total
F M F M F M F M F M
1979 T 38 15 31 6 28 14 1 4 98 39
D/F 28 12 20 2 7 5 0 1 55 ZO
% 73.6 80 64.5 33 25 35.7 - 25 56.1 5/. 3
1980 T 38 18 28 12 30 18 5 2 101 50
D/F 30 14 18 5 14 4 1 0 62 23
% 78.9 7A8 64.3 41.7 46.7 22 20 - 62.4 46
1981 T 37 10 20 15 29 17 7 4 93 46
D/F 32 5 9 4 9 2 1 - 51 11
% 86.5 50 45 26.7 31 11.8 14.3 - 54a 23.9
1982 T 30 16 19 15 32 13 7 5 88 49
D/F 23 9 12 7 9 1 2 1 IS
% 76.7 56.3 63.2 46.7 28.1 7.7 28.6 20 52,3 3 6 .7
1983 T 46 12 35 19 29 23 3 1 113 55
D/F 41 12 18 8 9 5 2 - 7 0 25
% 89 100 51.4 42.1 31 21.7 66.7 - 61.8 45.4
1984 T 60 18 31 15 23 27 7 6 121 66
D/F 50 8 20 5 8 4 1 1 7S l a
% 83.3 44.4 64.5 33.3 34.8 14.8 14.3 16.7 65.2. 27.2.
1985 T 75 32 35 14 25 22 5 3 140 71
D/F 63 23 24 4 12 5 - 1 99 33
% 84 71.9 68.6 28.6 48 22.7 - 33.3' 70.7 46.5
T = total DF = Disease free patients
% = no. of disease free patients as % of total.
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Table 5.20: W est o f  Scotland M elanom a D ata
5 year disease mortality from melanoma figures for patients presenting 1979-1985 
categorized by sex and Breslow thickness band
Breslow Measurement
Not
Year 0-1.49 
F M
1.5-3.49 
F M
>3.5 
F M
available  
F M
Total 
F M
1979 T 38 15 31 6 28 14 1 4 98 39
D 4 1 8 3 17 9 1 3 30 16
% 10.5 6.7 25.8 50 60.7 64.3 100 75 30.6 41
1980 T 38 18 28 12 30 18 5 2 101 50
D 4 1 5 3 12 11 3 2 24 17
% 10.5 5.6 17.9 25 40 61.1 60 100 23.8 3 4
1981 T 37 10 20 15 29 17 7 4 93 46
D 2 4 6 7 15 11 5 3 28 25
% 5.4 40 30 46.7 51.7 64.7 71.4 75 30.1 54.3
1982 T 30 16 19 15 32 13 7 5 88 49
D 0 4 4 4 13 8 5 4 22 20
% - 25 21.1 26.7 40.6 61.5 71.4 80 25 40.8
1983 T 46 12 35 19 29 23 3 1 ' 113 55
D 0 0 11 7 13 12 1 1
1 ^ 20
% - - 31.4 36.8 44.8 52.2 33.3 100 ) 22.1 36.4
1984 T 60 18 31 15 23 27 7 6 121 66
D 4 6 5 7 11 16 3 5 Z2> 34
% 6.7 33.3 16.1 46.7 47.8 59.3 42.9 83.3 51.5
1985 T 75 32 35 14 25 22 5 3 140 71
D 3 1 3 6 8 14 4 2 18 23
% 4 3.1 8.6 42.9 32 63.6 80 66.6 12.9 3X .tf
T = Total D = Dead of melanoma % = % dead of total
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There was an increase in the numbers of MMs registered each year in  the 
three years of the study and this continued at a similar rate in subsequent 
years. Overall in the 7 year period from 1984 there was a 47% increase in 
m elanomas in the West of Scotland. The 1985 figure shows an higher 
than expected annual increase of 11.8% from '84 with a further 14.4% rise 
to the 1986 level. The female to male ratio has altered over the years to 
1.5:1 compared to 2:1 in the prepublicity figures. The percentages of "thin" 
lesions in '84/85 and '86 were 41.2, 50.2 and 46.9 respectively. The 
difference between '84 and '85 was significant. The percentages of wom en 
MM patients presenting with thin lesions rose to 53.6% in 1985 while the 
male percentage rose by more than a half to 43.5% The percentages of thin 
lesions has improved significantly for both sexes over the years studied 
and the difference betw een the sexes is overall less m arked. "Thick" 
lesions constituted 25.7,22.5 and 23.8% of the annual totals in the study 
years. The greatest change related to sex was a dram atic fall in the 
percentage of men with thick lesions from 37.9 in 1984 to 24.7 in 1986.
5.3. Evaluation of melanoma data
The melanoma data for 1979-1990 was assessed to evaluate changes in 
total num bers, sex distribution,Breslow  thickness d istribu tion  and 
histogenetic type over time.
A computer package, EPI INFO (WHO) was used to calculate chi squared 
and probability values
Taking the whole of 1985 as the intervention year the data was aggregated 
to examine pre-intervention (1979-1984) figures and post-intervention
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* p = probability; df = degrees o f freedom, j
(1986-1990) ones. In addition com parisons w ere m ade across the 
aggregated years i.e. 1979 vs 1984, 1984 vs 1986 and 1986 vs 1990. The tests 
excluded all m issing or unspecified variables e.g. unclassifiable 
histogenetic types.
5.3.1. Breslow Thickness
Aggregated data for males, females and both sexes were compared for 
distribution across the 3 Breslow thickness categories in pre- and post­
intervention years.
Results:
Both sexes : Chi sq = 55.6 ; p=0 (approx); df=2*
Male only : Chi sq = 29.8 ; p=0 (approx); df=2*
Female only : Chi sq = 30.0 ; p=0 (approx); df=2*
For all three groups there is a highly significant relationship between 
Breslow distribution and time for the two aggregated periods.
For all the groups the dominant number of people had moved to the thin 
Breslow category in the post-1985 period at the expense of the other two 
thickness groups. Pre-1985 the dominant number of people were in the 
thicker categories.
Breslow thickness distribution was examined for the years 1979 vs 
1984, 1984 vs 1986 and 1986 vs 1990. No significant change was 
apparent before 1985. A significant shift firom thick to thin lesions was 
demonstrated for 1984 vs 1987 and for 1986 vs 1990 for both sexes.
5.3.2. Histogenetic types:
Aggregated data for males, females and both sexes were compared to 
look for a relationship between pre- and post-intervention years and the 
distribution among 5 types o f MM i.e. SSM, NM, ALM, LMM and 
"other".
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5.3.2. Results:
Both sexes : Chi sq = 28.7; p=0 (approx); df= 4 
Male only : Chi sq = 12.95 ; p=0.012; df= 4 
Female only : Chi sq = 18.9 ; p=0.001; df= 4 
Thus there are highly significant differences in the distribution of types 
between the two time periods. Post-intervention years see a shift in 
distribution towards more SSMs with decreases in NMs, ALMs and 
"others".
No significant difference for types was found by comparing the data for 
1979 vs 1984, 1984 vs 1986 or 1986 vs 1990.
5.3.4. 5 year follow up data:
A relationship was sought between number of patients alive (disease 
fi’ee) and those dead in each thickness category, for the 5 histogenetic 
types, for males and females separately and between different years of 
presentations.
Results: Thickness categories. Both sexes
1979: Chi sq = 26.9; p=0 (approx); df= 2 
1982: Chi sq=  19.3; p=0.0001; df= 2 
1985: Chi sq=  19.2; p=0.0001; df= 2
For all years those with thick tumours formed the greatest proportion of 
those dead and the smallest of those alive. The same pattern was seen 
for males and females separately with very similar Chi squared values.
There were no significant differences between the sexes, histogenetic 
types or between different years o f presentation.
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CHAPTER SIX
DISCUSSION
Thus far, m ost educational work in the field of melanom a has been 
directed at secondary preventive measures, m ainly tow ards the early 
diagnosis of lesions. The possible beneficial effects of education and 
earlier diagnosis can only be accepted if a correlation exists between delay 
in diagnosis and poor prognosis MMs. The assessment of delay data is 
difficult as it relies largely on the patient's recall which may be faulty. It is 
likely, however, that this inaccuracy is present to similar degrees in most 
delay studies and thus their results can be usefully compared. Most of the 
small num ber of studies of delay in melanoma patients have tried to 
correlate delay w ith the current gold-standard prognostic indicator, 
Breslow thickness. Data of 125 Glasgow MM patients studied before the 
education campaign showed that the great majority delayed more than 
three m onths before seeking advice and the commonest explanation 
offered for this behaviour was lack of know ledge of the possible 
significance of their changing pigmented lesion. (117) In a more recent 
study  post-dating  educational ventures in America, Cassileth and 
colleagues (146) found evidence of both physician and patient delay in a 
group of 275 patien ts w ith invasive MM. Physicians w ho rated 
themselves as having "substantial" or "expert" knowledge of MM were 
m ore likely to correctly identify the lesion. Patients studied  were, 
irrespective of general education status, unable to distinguish betw een 
benign pigmented lesions and MM. Women had longer mean delays (3.3 
months) than men (1.9 months) a factor also noted in the Glasgow study.
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Before the start of the West of Scotland campaign, the demonstration of 
lack of knowledge of MM among MM patients was taken as an indication 
of poor MM knowledge amongst the Glasgow population as a whole. 
Newm an and colleagues evaluated public knowledge of skin cancers in 
several o ther British tow ns before the Cancer Research Council 
sponsored 7 centre campaign. (147) Their assessment was made by postal 
questionnaire to 250 individuals selected from the electoral ro lls of each 
of five towns. Response rates varied among the towns from 56 to 72% 
w ith  an overall figure of 63%. Sex and age d istribu tion  of the 
respondents was sim ilar to that of the general population, 47% of 
respondents being male and 48% aged > 45 years. Only 26% of people had 
heard of the term  "melanoma" though 28% rem embered some type of 
publicity about moles an d /o r MM. Half of the latter group had received 
the information from television. Nearly all the respondents said that 
skin cancers could be cured by early treatm ent but curiously the most 
commonly cited method of treatment was laser. The questionnaires were 
assessed to give an overall knowledge score. Scores were higher for 
women, those educated beyond the age of 17 years and for non-m anual 
social classes. There were no significant differences in scores for the 
different tow ns or am ong different age groups. This w ork thus 
dem onstrated a generally poor level of MM knowledge in the towns 
studied and a comparison with the West of Scotland population would 
have been interesting.
Efforts have been made to reduce delay in the presentation of tum ours 
other than MM. A study from Southam pton looked at delay in 
presentation with symptomatic breast disease in the years during, before 
and after a public education campaign. Whilst there was a trend to less
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delay after publicity this was not very marked. On closer evaluation it 
was shown that those women who presented in less than 3 m onths pre­
education presented even more quickly after it. The proportion  of 
wom en w ith long delays was unchanged throughout the 3 year study 
period. On the positive side the greatest decrease in delay after education 
was seen in those aged over 65, the age group at highest risk of malignant 
disease. (148)
Public education seems to be a logical approach towards the correction of 
a recognised deficiency in knowledge. In the current British health care 
system referrals to hospital specialists occur through GPs. Any public 
health venture which is to be evaluated through hospital acquired data is 
best carried out with the co-operation of the GPs in the target area. A pre­
campaign questionnaire distributed to Glasgow GPs showed a desire for 
the public education program m e preferably preceded by professional 
update. This initial enthusiasm was confirmed by the large attendances 
at subsequent m eetings and by requests for cam paign m aterials. 
Professionals other than doctors are very im portant in MM education 
and thus nurses, who frequently see the less socially visible areas of 
patients bodies, were also targeted in the Glasgow MM campaign and 
information was received by them with great enthusiasm.
During the professional campaign much of the education was possible on 
a small group basis in surgeries and health centres. Evidence from breast 
cancer education work suggests that individual or small group teaching is 
the most effective method of education. (126) The main materials used 
as teaching aids during this phase of the Glasgow campaign were booklets 
and a clinically orientated video tape presentation. The presence of one of
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the cam paign derm atologists on these occasions allowed for informal 
questioning and clarification of the points raised in the teaching material. 
Fairly detailed inform ation could be prov ided  to supplem ent the 
comprehensive booklets. Whilst it is likely that those GPs attending 
these sessions improved their level of knowledge of MM it is impossible 
to assess w hether this altered their m anagem ent of patien ts w ith  
pigmented lesions. There was a small rise in referrals to the PLC during 
-the update  suggesting either increased aw areness of the possible 
seriousness of pigmented lesions or of the availability of the PLCs facility 
for rapid referral.
A few studies have attempted to assess behavioural change among small 
professional education target audiences and some have show n that 
whilst there may be a demonstrable im provem ent in knowledge this 
does not necessarily produce a better patient outcome. In one study (149) 
it was noted that medical staff failed to follow up 90% of major laboratory 
abnormalities detected on their patients. After education, there was no 
improvement noted in this rate. Another American study showed that 
there was no direct relationship betw een level of know ledge and 
percentage of correct diagnoses reached in two groups of physicians 
assessing the same 133 patients with urinary tract problems. (150)
The professional update formed only a section of the Glasgow MM 
campaign. Patient outcome measures like the proportion of MM patients 
presenting w ith thin lesions were interpreted as being due to the whole 
campaign and the effects of individual components were not evaluated. 
When a target audience is large and not uniform  a variety of messages 
and types of m edia are required to reach the m axim um  num ber of
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people. Thus for the public education com ponent of the cam paign 
different educational methods were employed than had been used in the 
professional update. The two components were linked, however, by the 
use of the 7 poin t check-list. This compact list was felt to be an 
appropriate m ethod of getting the key message to the maximum num ber 
of people. Similar messages have been derived for the public campaigns 
in Queensland (Slip, slap, slop) and in USA (ABCDE). The form er 
advocates the slipping on of a T shirt, slapping on a hat and slopping on 
sunscreen. The American mnemonic is similar to the 7 point list in 
giving features to check during self-examination of pigmented lesions (A 
- asymmetry, B - border, C - colour, D - diameter,E - elevation).
Although it is widely accepted that public education is probably "a good 
thing" there is very little evidence to support this assumption. Very few 
public education program m es have been evaluated in term s of their 
effects on public knowledge, and their success or failure is usually judged 
by assessment of patient outcomes e.g. mortality data. The middle step in 
this system  i.e. w hether im proved know ledge results in a ltered  
behaviour has not been questioned and indeed it w ould be difficult to 
imagine a good m ethod of doing this. In the Canadian Breast Cancer 
Study participants were divided into those who had a single examination 
and those who were eligible for rescreening on an annual basis. Those 
who were reviewed annually were assessed as to their competence in 
breast self exam ination (BSE). It was show n that individuals w ho 
complied w ith the re-screening requests improved their competence and 
frequency of BSE. (151) It seems reasonable to assum e that this 
behavioural change was at least in part due to increased knowledge. 
Robinson has looked at behavioural change produced by education in a
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group of 1042 patients who had had surgery for non-m elanom a skin 
cancer. (152) Patients were given verbal and w ritten advice on sun 
protection. This included altering behaviour by limiting sun exposure, 
changing time of day of that exposure and use of sunscreens both of a 
chemical and clothing type. One year after surgery patients were sent a 
questionnaire to assess their compliance. It was found that 38% of those 
who replied were not complying with the offered advice. Patients aged 
over 65 years tended to be less compliant. In addition a health risk taking 
group was identified among the non-compliers. These tended to be 
wom en who did not perceive a significant benefit from the proffered 
advice to counteract the perceived cosmetic disadvantages of lack of tan 
and stickiness of sunscreens. Such women tended to be smokers who 
had not attended for available screening measures like cervical smears or 
mam m ography. While the level of compliance achieved in this study 
may seem quite good initially it m ust be remembered that certain factors 
in the work were unusual and thus similar results could not be expected 
with true public education. Firstly, the population involved was highly 
selected in that all had had sun-related skin tum ours requiring surgery. 
Secondly, education was given verbally on two separate occasions on a 
one-to-one basis which is recognised as the best method of transmitting 
information. (126)
The benefits of less individualised m ethods of health education are 
difficult to m easure and thus little data is available from  other 
educational w ork to compare the effect of publicity of the Glasgow 
education campaign. A few other health cam paigns have m easured 
patien t outcom es like m ortality or factors like stage at the tim e of 
diagnosis to give some indication of their effectiveness. The Edinburgh
102
Breast Cancer Study assessed women's knowledge of various facts about 
breast cancer especially breast self examination before (124) and after 
education.(125) A year after the campaign there had been a small but 
significant increase in knowledge.
The N orth Karelia Project directed major publicity on cardiovascular 
health specifically to one county in Finland. Subjects covered included 
possible preven tative  strategies like advice on low fat d iet and  
inform ation to raise public aw areness on card iovascular health . 
Subsequent data  show ed that the trend  tow ards a reduction  in 
cardiovascular diseases noted for Finland as a whole were m uch more 
m arked in N orth Karelia than in the other counties w here no such 
education had taken place. (153) The assum ption was that the five year 
education project had been responsible for this good outcome. Critics of 
the project comment that although an improved level of knowledge on 
cardiovascular matters was demonstrated in the target population after 
education no attem pt was made to establish whether this had resulted in 
a behavioural change. (154) Thus a direct connection between education 
and improved patient outcome could not be proven.
Experience in other fields of cancer education has show n that public 
education will result in increased referral of patients. Even if the general 
practitioner is trained prior to the public education it is likely that they 
will feel the need to refer some of the patients presenting post-publicity 
for a specialist opinion. Following the Glasgow melanoma cam paign 
there was a significant rise in pigm ented lesions seen at v irtually  all 
derm atology clinics in the city. At the W estern Infirm ary PLC the 
increase was mainly due to seborrhoeic keratoses and benign naevi. The
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proportion of MMs seen at the clinic fell in 1985 com pared to 1984 
although the actual num ber of MMs increased in both  1985 and 
1986.Thus the increased num bers of referrals actually d ilu ted  the 
proportions of MM seen at the PLC.
Although no formal change in management of pigm ented lesions at the 
clinic w as m ade, the m arked increase in new patien t num bers was 
associated w ith an alteration in the proportion of patients biopsied. In 
1985 w hen the num bers first increased almost half of the new lesions 
seen were biopsied. In 1986, however, this proportion fell m arkedly 
despite a further rise in numbers of patients being seen. Biopsy results in 
a considerable increase in w orkload com pared to sim ple clinical 
examination. Each biopsy requires further medical and nursing time and 
also time for processing in the pathology laboratory.
In the assessment of the workload of the PLC data was not gathered on 
reasons for proceeding to biopsy. The possible reasons are 1) to make a 
diagnosis, 2) to reassure the patient and 3) for cosmetic reasons.
In both 1985 and 1986 no patients had a lesion excised urgently  on 
cosmetic grounds. It is likely that fewer lesions were biopsied in 1986 as 
increase in confidence in clinical diagnosis made it unnecessary. By 1986 
the medical staff regularly doing the PLC had considerable experience in 
the diagnosis of pigm ented lesions and had had the opportunity  to 
correlate the clinical and pathological features during 1985. There would 
be no obvious reason for a reduction in the proportion of patients 
requiring biopsy for reasons of reassurance in 1986.
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The increase in clinical confidence would be a useful skill to pass on to 
other health care professionals. Many GPs freely adm it that they are 
uncertain about the nature of some pigmented lesions. This may reflect 
the relative infrequency with which they see such lesions in the surgery. 
Even after publicity in Nottingham  (155) the GPs canvassed were only 
seeing an average of 3 pigm ented lesions a week. It could be w orth 
developing the experience of one or two GPs in each health centre by 
offering them  the chance to attend a PLC regularly to m aintain their 
confidence. This w ould perhaps prevent individuals w ith  common 
lesions like seborrhoeic warts and benign naevi being referred to hospital.
In the periods following publicity the observation that m any of the 
referrals to PLCs throughout the country were of benign non-melanoma 
lesions led to a review of the 7 point check-list. It had been recognised at 
the outset that some benign lesions could score several points and thus 
that its use by GPs might not prevent referral of these lesions to hospital. 
Professor Mackie herself recognised the possible flaws in the original list 
and after further extensive review of melanomas produced a revised 
version in 1989. (156)
Other groups have tried to formally assess both the original and the 
revised version. Higgins and colleagues evaluated both versions in 
consecutive patients attending their PLC w ith histologically confirmed 
benign pigmented lesions.(157) Lesions were scored by both doctor and 
pa tien t and the scores com pared. D octors categorised 30% of 
histologically proven benign lesions as "suspicious" using the 1985 list 
and 70% using the 1989 one. The patients own score was very similar 
with both versions of the list. The doctors also gave each lesion a clinical
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diagnosis independent of the score and 99 of 100 lesions were correctly 
diagnosed as being benign. One lesion was clinically suspected of being a 
melanoma and proved on histology to be a dysplastic naevus. This work 
was performed by a number of clinicians and the degree of inter-observer 
variation was not assessed. The case mix for the London PLC in the study 
was quite different from the Glasgow one. In Glasgow 60% of lesions 
were seborrhoeic warts or benign naevi while those constituted 86% of 
lesions assessed in the London study. Perhaps the latter difference may be 
of relevance as it means that lesions like atypical naevi,dermatofibromas 
and angiomas were under-represented..
The same group of workers evaluated the original 7 point check-list by 
looking at clinical photographs of 100 proven m alignant melanomas. 
They found that half of the lesions seen scored less than 3 on the check­
list. As they were all biopsied there m ust have been some suspicious 
features which led the doctors to proceed to biopsy despite the low score.
(158)
Finally Keefe and colleagues evaluated the original check-list in a series 
of 195 patients with a variety of pigmented lesions. They noted predictive 
values of 64% and 99% respectively using doctors* scores but only 7% and 
99% for patient ones. The single feature which best distinguished MMs 
from benign lesions was the doctors recognition of an irregular margin
(159). None of the patients recognised the irregularity of the m argin and 
also found it difficult to recognise variation in pigmentation throughout 
their lesions.
As yet no alternative to the check-list has been suggested. The features 
largely agree with those used by the American Cancer Society and those
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used in melanoma publicity in Australia, New Zealand an New Mexico. 
It may be that they will continue to prove the most useful form of advice 
to publicise.
All the educational m aterial including check-lists relates mainly to the 
superficial spreading variety of melanoma though it would also apply to 
most lentigo maligna and acral lentiginous varieties too. The type of MM 
least likely to be diagnosed or suspected from the check-list would be the 
n odu lar one w hich often lacks the irregu lar edge and variable 
pigmentation. The lack of a clear radial growth phase may mean that 
even those presenting prom ptly on noting any change may already be 
quite thick in terms of Breslow measurement.
The next phase to consider may be a modified educational message to 
encourage early diagnosis. For adults the check-list could probably be 
summed up into a one word message - "change". This would cover six of 
the original seven points and would apply whether the change was noted 
by the patient, relative or friend or health care professional. Perhaps an 
enquiry as to changing pigmented lesions could be included as part of all 
general medical examinations, e.g. those conducted by GPs on their older 
patients. Younger people could be questioned when attending the surgery 
for other problem s or w hen attending Well Women, family planning 
clinics or sports medicine clinics. Any lesion which had altered could 
then be evaluated using the 7 point check-list (or a future alternative) and 
further referral made if indicated. If the public education message was 
made more vague it is possible that many more people would seek advice 
and thus further professional education would be required to improve 
GPs and non-specialist doctors confidence in assessing pigmented lesions.
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The factor which is not included in either of the versions of the Glasgow 
checklist is the doctoi*s clinical diagnosis of the lesion.Irrespective of 
actual scores^ an experienced doctor w ould be able to recognise most 
seborrhoeic warts by their characteristic warty, "stuck on" appearance. 
Likewise^ many doctors will appreciate the differing appearance of a 
patient's MM from that of their other pigmented lesions even if it has a 
low score.
In the Glasgow campaign the marked rise in pigmented lesions referred 
was taken as an indication that the publicity  had  been effective. 
Evaluation of the benefits of the campaign and thus its true success is 
much more difficult. At first sight the marked increase in melanomas 
and in particular in thin ones in 1985 seemed to imply that the publicity 
had encouraged people to present w ith thinner lesions reflecting their 
increased knowledge of melanomas.
The best method of assessing the effect of any intervention like public 
education is to m easure outcomes and knowledge before and after a 
limited time of intervention. A study population should be compared 
w ith a similar control population who have not been exposed to the 
in tervention.
This had been the original plan w ith the Glasgow melanoma campaign. 
In practice, the plan proved impossible to follow. The public education 
intervention, intended to concentrate on June and July 1985, continued to 
appear throughout the whole of 1985 and to a more limited extent in 
1986. Due to the extremely limited funding of the venture very little 
publicity was actively sought after June 1985. The campaign was widely 
reported as information spread by a "snowball" effect to a variety of
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media. As the publicity also went national rather than remaining local, it 
was impossible to monitor the planned control population.
The fact that 1987 saw the multicentre version of the Glasgow campaign 
launched m eant that there was never an opportun ity  to sam ple 
knowledge (delay in diagnosis) in the Glasgow MM patients in the 
absence of active publicity and to separate the effects of local and national 
ventures. Further publicity has been given to m elanom as and their 
diagnosis ever since 1985. During the planning of the 1985 campaign it 
was felt that annual reminder campaigns might be required and this now 
effectively occurs.
The most useful outcome m easure for cancer education ventures is the 
mortality data. Reduction in mortality can be interpreted as a successful 
campaign result but the reduction must be of a certain size to offset the 
cost of the campaign in order to be regarded as being cost effective. In 
breast cancer work, long term follow up has allowed calculations to be 
made to estimate cost of diagnosing cancers by screening and some doubt 
exists as to w hether any improvement in m ortality and m orbidity has 
been worthwhile. Mortality data gathered by the SMG has shown a fall in 
melanoma mortality from 1988 onwards for women but not for men. (18) 
This w ould be in keeping w ith im proved proportions of thin lesions 
especially in women. Longer follow up w ould be required to assess 
whether this trend was to continue and be seen in males too.
The m ain interm ediate m easure of the MM education venture is the 
proportion of thin, good prognosis lesions seen. The proportion of thin 
lesions was significantly higher in 1986-90 com pared w ith  the p re ­
campaign years. There was a concomitant fall in the proportion of thick
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lesions. It is impossible to prove that the public education was the cause 
of the change. The annual melanoma figures for the West of Scotland 
only were too small to determ ine definite trends bu t there w as no 
evidence of any emerging trend towards thinner lesions in 1979-84 before 
any publicity.
If education was the cause of the change in the proportions of different 
thickness categories of MM the apparently better uptake of educational 
m aterial by wom en could partially explain the larger increase m thin 
lesions in women after 1985. The rapidity with which the CRC 7 centre 
campaign followed the Glasgow one makes it difficult to distinguish a 
point where the effect of one stopped and the other started. Data from 
Nottingham and Glasgow showed that more women than men attended 
PLCs in 1985. This was regarded as possibly being a good thing as twice as 
many women had MMs.
Further work from Scotland (160) for 1979-89 has shown that the greatest 
increase in MM incidence was in older m en who also had the greatest 
proportion of thick lesions. A study from New South Wales found that 
thick MMs were more common in older men.(120) In both studies the 
highest proportion of thick lesion were on the head and neck.
A recent study from USA (161) found that MM mortality increased to 50% 
for men between 1973 and 1988 compared to only 21% for women. The 
greatest rise occurred in those over 50 with a peak in the 80-84 age group. 
O ther workers had shown im proved 5 year survival figures for MM 
patients as a whole from 41% in 1983 to 83% in 1985.(162) These authors 
attributed this change to their public education ventures.
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The above data suggests that future educational ventures should make 
special efforts to reach older men. This section of the population lacks the 
easily identifiable inform ation sources like w om en's m agazines and 
sports facilities which reach women and younger people respectively. It 
is possible that the recent introduction of regular health checks by GPs for 
their older patients may allow this group to be informed and screened.
For education to be successful there m ust be some increase in the level of 
know ledge w ithin the target group although there is no proof that 
improved knowledge alters behaviour.The level of knowledge on MM in 
the West of Scotland was not assessed before or after the campaign. This 
was largely due to constraints of finance and personnel before the 
cam paign and to the continuous publicity in the years after it.(v.s.). 
Indirect estimates of knowledge were taken from patients attending the 
PLC, 66% of whom were aware of the campaign.
R ecent B ritish  w ork by N ew m an et al (147) and W hitehead  et al 
(155) m easured  know ledge o f m elanom a in  a m ulti-tow n postal 
survey and a PLC respectively . In the form er only 26%  o f  those 
surveyed had heard  o f  M M  and only very few  knew  tha t skin 
cancers could  be life  threatening.
In Nottingham (155) over 70% of patients were aware not only of MM but 
of the 7 point check-list. This study was carried out before the 1987 CRC 
campaign. The high level of knowledge may be partly explained by the 
fact that the population was a selected one. As the only publicity at that 
time on the 7 point checklist was from the Glasgow campaign the high 
level of awareness in Nottingham m ust reflect spill-over publicity.
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Countries w ith high MM incidence like Australia have longer experience 
of public education and there 90% of people surveyed had heard of MM 
and were aware that skin cancers could be dangerous. (163) Perhaps this 
level of know ledge in the population  only appears after repeated 
educational ventures.
One possible detrim ental effect of public education is an increased 
workload for GPs and hospital services with the implications this could 
hold for health  service budgets. The results of the G lasgow and 
Nottingham  campaigns suggest that the increase in workload is not too 
great.In Scotland where hospital waiting lists are short there has been no 
suggestion that the increase in pigmented lesion referrals caused undue 
delays for other patients. In the W est of Scotland this possibility was 
largely avoided by channelling pigmented lesion referrals to a designated 
PLC. In parts of the country without this facility continuing educational 
ventures may be causing increases in waiting lists.
The Glasgow and Nottingham  experience was that at least ten benign 
lesions are seen for each MM at their PLCs. Obviously m any m ore 
patients will have consulted their GPs and not been referred on. As yet no 
figure is available for a cost per MIA diagnosed.
The other potentially adverse effect of education observed in the cancer 
field has been an increase in patient anxiety. Particular attention has been 
given to the anxiety generated by population based screening eg for breast 
and cervical cancers and general health  assessm ents. (164). It is 
recognised that even inviting people for screening m ay cause anxiety 
which m ay not be totally corrected by a norm al result. (165). Other 
workers have shown that such anxiety can be reduced by providing more
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information w ith the screening information, at the time of attendance for 
the screening test and with the result. (166) If the screening test result 
produces referral to hospital for further investigation, this invitation may 
further increase anxiety. A study of women referred to a hospital cytology 
clinic after an abnormal smear result found that the group who were sent 
an explanatory leaflet w ith the appointm ent card were significantly less 
anxious than those who were not. (167)
During the Glasgow campaign no attempt was made to formally measure 
anxiety related to attending the clinic. It was common, however, for 
individuals to express relief when told that their lesion was benign. This 
aspect of work would be a useful study for the future as would levels of 
anxiety in patients attending their general practitioner for a preliminary 
(screening) examination.
The alternative means of encouraging earlier diagnosis of MM is to 
consider screening either of the whole population or of identified high 
risk groups. The nature of MM makes it an attractive target for a 
screening programme. It is increasing in incidence and mortality making 
it a public health problem, the screening test (clinical examination) is 
rapid and patient acceptable and there is evidence that early diagnosis 
improves prognosis.
Screening for melanoma has been carried out in a series of Skin Fairs in 
USA. One or two day fairs are held in shopping malls and other public 
places, staffed by derm atologists who offer their services free. The 
screening is preceded by considerable publicity including the ABODE 
checklist. Those individuals suspected of having a melanoma or other 
skin cancer are advised to have the lesion excised prom ptly. As this
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m eans that the histological diagnosis is not easily available to the 
screening organisers, it has proved difficult to accurately assess the 
num bers of melanomas found. Koh and colleagues have followed one 
group of screened patients and calculated a predictive value of 35-40% for 
visual screening examination for melanoma (142)
More recently visual screening was conducted in a beach location in the 
Netherlands (168) A total of 3,069 people were examined, 65 (2.1%) were 
found to have suspicious lesions and these individuals were referred 
back to their GPs. Subsequent histology showed that this group included 
6 melanomas, 2 squamous cancers, 23 basal cell cancers and 5 dysplastic 
naevi. This gives an approxim ate rate of 1 MM per 500 individuals 
examined. Only 80% of those referred back to their GPs complied and 
histology was available for 19 of the suspicious lesions.
At present no plans exist to extend MM screening to the general 
population in Europe.
Some attention has been given to the possibility of screening high risk 
groups. Greene and colleagues (37) followed up families w ith dysplastic 
naevus syndrom e. All the melanom as identified at these screening 
examinations were very thin and thus there has been no mortality in this 
group. Data has recently been published from the Glasgow PLC on 116 
patients w ith different types of atypical naevi. The m edian thickness of 
the melanomas detected at follow up was only 0.75 mm.(169).The highest 
risk of MM was in those with atypical naevi and family histories of MM. 
(Relative risk-444) Lesser risks were identified in those w ith  atypical 
naevi and personal histories of MM (Relative risk-91) and those w ith 
atypical naevi only (Relative risk-92).
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Thus is may be appropriate to suggest limited screening for MM of high 
risk individuals and perhaps this should be done through specialist 
clinics initially. In view of its com parative rarity  it m ay not be 
appropriate to suggest large scale screening programmes in Britain until 
there was good evidence of its value from pilot studies. Large scale 
screening w ould require specific training for either medical or nursing 
personnel as numbers of dermatologists in Britain could not take up this 
workload. Until then it is probable that screening will rely on general 
practitioners and other prim ary care health workers. It is essential that 
regular update programmes are planned for these individuals.
The situation in high incidence countries like Australia is som ew hat 
different. There, State Cancer Councils | suggest regular self screening 
and annual doctor screening for all. A recent study for New South 
Wales examined the prevalence of screening in a group of 1344 people. 
Only 48% regularly examined their own skin or had it examined by their 
partner. A further 2% had had an examination by a doctor within the last
year, j The value o f  th is type o f  screening is not yet proven .
The study showed that male gender, lower social class, unemployment, 
physical inability to work and lack of secondary education characterised 
those who had not been screened. (170)
In contrast this group in Australia found that those with real or perceived 
increased risk of melanoma and those aware of the benefits of its early 
diagnosis were most likely to be screened.
At the Glasgow PLC those w ith a possible increased risk of melanoma 
were instructed in self screening. In addition those w ith atypical naevi
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were followed at variable intervals at the clinic. This has allowed for 
early diagnosis of new MMs and assessment of risk (169)
At present, therefore, most melanoma w ork is likely to rem ain in the 
field of early diagnosis and education until a clearer picture of the value 
of screening emerges. Attention should be given to improvem ents and 
alterations to the education programme. As mentioned previously, the 
publicity seems to be virtually self-generating and to attract public 
interest, it is important that the best type of message is selected to reach 
those most in need. In Glasgow, the 7 point check-list has been modified 
(171) and the publicity leaflet updated to give a more "user-friendly" 
layout.
The situation regarding preventative m easures in melanoma is not yet 
clear. Global issues like ozone depletion need to be addressed urgently 
and steps taken to at least decelerate current rates of dam age to the 
environment. In 1987 the Montreal Protocol on substances recognised to 
deplete the ozone layer was signed by 35 countries. This aims to fix levels 
of chlorofluorocarbons production initially then gradually reduce them. 
While such endeavours will perhaps slow the rate of ozone thinning, 
more restrictive legislation would be required to arrest it completely. 
Thus if ozone thinning is even partly responsible for increasing MM 
incidence the rise would continue for several more decades even if such 
legislation was undertaken at once. (172)
On a smaller scale, in view of the undeniable relationship between MM 
and UV exposure, it seems reasonable for health care professionals to 
advocate sensible sunning for all. This requires a behavioural change 
among both the general population and particularly those at high risk.
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The most appropriately aged targets for this type of information may well 
be children and teenagers given that it appears that sun exposure at this 
age confers a lifelong MM risk. In addition, it is at this age that people 
become aware of fashions and body image. A school based skin cancer 
prevention project is underw ay in the high incidence area of Arizona 
(173) and in London (174). If tomorrow 's adults were convinced of the 
damage potential of excess sun exposure perhaps the rising incidence of 
MM could be halted.
Adults too should be educated to assess their natural tolerance and use an 
appropriate sunscreen either chemical or physical (clothing). In recent 
years both the cosmetic acceptability and efficacy of the chemical types 
have greatly im proved. Hopefully, this, together w ith  appropria te  
publicity, should encourage more widespread use of these agents.
The hoped for result of good sun screening would ultimately be a halt in 
the increase in MM incidence. Monitoring of the level of sunscreen use 
w ith in  com m unities w ould be helpful in evaluating their possible 
benefits.
The National Institutes of Health Concensus Development Conference 
on the diagnosis and treatm ent of early M M  has recently published its 
findings.(175) Amongst their conclusions it was stated that education and 
screening programmes have "the potential to decrease the m orbidity and 
m orta lity  from  m elanom a". This docum ent adds w eight to  the 
continuing development of education programmes.
For the future, the search for aetiological factors in MM m ust continue 
and further effort must be directed towards finding an explanation for the
117
rising incidence and mortality rates. In the meantime, improved general 
knowledge of MM and more widespread recognition m ust remain a goal 
for those working in this field.
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APPENDIX A
General Practitioner Questionnaire.
1. The recognition of early m alignant melanoma is a subject 
about which in general GPs are not confident because of its 
relative rarity.
Agree. O  Disagree O
2. If the following forms of m aterial were available to help 
compensate for this lack of personal experience, which would 
you consider would be most useful?
(i) Video tape presen tation  of representative cases for 
practice or home use. EU
(ii) Tape slide presentations. ED
(iii) A short illustrated booklet for instant reference in the 
surgery. ED
(iv) Small local meetings w ith an "expert" lecturer, followed 
by discussion. ED
(v) A tape to play in your car or at home. ED
(vi) A recorded telephone message. CD
3. Which of the above would you anticipate being most useful 
to the majority of GPs?
4. Do you consider that the needs of trainee GPs, as far as this 
topic is concerned, are different from those of established GPs?
Yes. ED N o CD
If yes, could you say how?
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5. Which of the following possible topics for educational leaflets 
would you consider most GPs would find helpful in this area 
of knowledge?
Value to GP
Definitely useful Probably useful Not of great 
and interesting interest
Early recognition of malignant melanoma and its differential 
diagnosis
□ □ □
Normal benign melanocytic naevi (moles) from birth to death
□ □ □
Pathology of melanoma
□ □ □
Current approaches to surgery of primary melanoma
□ □ □
The m anagement of advanced melanoma
□ □ □
M elanoma and pregnancy-w hat advice is appropriate  for 
young female patients
□ □ □
The epidemiology of melanoma around the world
Dermatological dangers of excessive sun exposure
□ □ □
6. Do you have any personal anecdotal case history of practical 
experience in this field which m ight be used ( anonymously 
or not, as you wish) for the educational exercise?
Yes. O  N o im
133
if yes , we will contact you in the near future.
7. W ould you welcome more information on the appropriate
procedures to initiate if a patient walks into your surgery with 
a suspect melanoma?
Yes. CD N o CD
8. W ould you welcome inform ation on current appropriate
therapeutic procedures for melanom a in order to inform  
patients of the likely course of events?
Yes. CD No. CD
9. W ould you welcome educational material or an educational
campaign aimed at your patients to encourage them to attend 
for exam ination  of "odd moles" and possib le  early  
m elanom a?
Yes. CD No. CD
Only after the GP programmehas been distributed. CD
This questionnaire  is a genuine a ttem pt to determ ine w hat GPs 
themselves feel are the educational deficiencies in this area and how to 
correct them.
Please return this questionnaire in the enclosed reply paid envelope and 
distribute copies to your partner and trainees.
134
APPENDIX B
Pigmented Lesion Clinic Questionnaire.
(please tick appropriate box)
5.
Age range.
0-20yrs CH 20-40yrs O  40-60yrs O  Over 60 CH
Sex.
Male CH Female CD
Before your recent hospital attendance had you heard 
anything about the Skin Cancer Campaign?
Yes □  N o □
If yes please answer question 4.
Can you put a tick(s) beside the way you heard about the 
campaign.
Newspapers 
Glasgow Herald 
Daily Record 
Sunday Mail 
Scotsman 
The Times 
The Guardian 
The Observer 
Other
Posters/Leaflets
TV /radio 
BBC News (TV) 
Breakfast Time 
W oman's H our 
BBC Radio 4-"Today" 
Reporting Scotland 
Bodyline 
Radio Clyde 
Jimmy Mack 
What's Your Problem
If you answered no to question 3 can you say why you went to 
see your GP about the mark on your skin eg was it following 
advice from a relative or friend?
Please return the completed form in the enclosed envelope. 
Many thanks for your time and co-operation.
135
GLASGOW
UNIVERSITY
l ib r a r y
